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1. List of abbreviations 
ADCK   AarF domain containing kinase  
ATP   adenosine triphosphate 
BCAA   branched-chain amino acid 
BCAT   branched-chain amino acid transaminase 
BN-PAGE  blue native polyacrylamide gel electrophoresis 
BTHS   Barth syndrome  
CL   cardiolipin 
CoQ    coenzyme Q  
DNA   deoxyribonucleic acid 
EMC   ER membrane protein complex 
ER   endoplasmic reticulum 
ERMES  ER-mitochondria encounter structure 
GFP   green fluorescent protein 
HA   hemagglutinin 
LC-MS  liquid chromatography coupled with mass spectrometry 
IMS   intermembrane space 
MAM   mitochondria-associated membrane 
Mcp   mdm10 complementing protein 
MCS   mitochondria contact site 
MDM   mitochondrial distribution and morphology 
MEF   mouse embryonic fibroblasts  
MFN2   mitochondrial protein mitofusin 2 
MIM   mitochondrial inner membrane 
MLCL   monolyso-CL 
MOM   mitochondrial outer membrane 
MS   mass spectrometry 
mtDNA  mitochondrial DNA 
NVJ    nuclear vacuolar junctions  
OXPHOS   oxidative phosphorylation  
PA   phosphatidic acid 
PC   phosphatidylcholine 
PE   phosphatidylethanolamine 
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PG   phosphatidylglycerol 
PI   phosphatidylinositol 
PK   proteinase K  
PLs   phospholipids  
PS   phosphatidylserine 
PVDF   polyvinylidene fluoride 
ROS   reactive oxygen species 
SDS-PAGE   sodium dodecyl sulfate polyacrylamide gel electrophoresis 
TCA   tricarboxylic acid  
TLC   thin-layer-chromatography 
vCLAMP  vacuole and mitochondria patch 
ΔΨ   membrane potential 
WT                           wild-type 
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2. Summary 
The proper function of mitochondria critically depends on their membrane lipid 
composition. To ensure lipid homeostasis, de novo synthesis, intracellular and 
intraorganellar transport, remodeling, and degradation of lipids must be tightly 
regulated.           
 Several studies have emphasised the importance of the mitochondrial 
signature phospholipid, cardiolipin (CL) for the organelle function. The acquisition 
of mature CL species is catalyzed by the phospholipid acyltransferase, Tafazzin. 
The importance of CL remodeling is underscored by the fact that mutations in 
Tafazzin lead to a life-threatening genetic disorder, Barth syndrome (BTHS). 
Currently, the biochemical processes underlying this clinical disorder remain 
unclear. Deletion of the yeast homologue Taz1 results in similar phenotypes to 
those observed in patients suffering from BTHS, making this organism an optimal 
model system to study the pathomechanism of the disease. To shed light on the 
pathomechanism of BTHS, I searched for yeast multi-copy suppressors of the 
taz1Δ growth defect and identified the branched-chain amino acid transaminases 
(BCATs) BAT1 and BAT2 as such suppressors. Similarly, overexpression of the 
mitochondrial isoform BCAT2 in mammalian cells lacking TAZ improves their 
growth. Accordingly, supplying both yeast and mammalian cells lacking Tafazzin 
function with certain amino acids restored their growth behavior. Although 
elevated levels of Bat1 or Bat2 did not restore all the mitochondrial defects of 
BTHS, it could correct the higher respiration rate observed in taz1Δ cells. These 
findings outline that the metabolism of amino acids can influence the BTHS 
phenotype and has an important and disease relevant role in cells lacking 
Taffazzin function.         
 In another project, I investigated the transfer of lipids between 
mitochondria and vacuoles. The absence of documented mitochondrial vesicular 
lipid exchange suggests that membrane contact sites (MCSs) facilitate lipids 
transport between mitochondria and other cellular membranes. Recently, it has 
been demonstrated that the lack of one contact site leads to the expansion of an 
alternative one. Specifically, loss of the ER-mitochondria encounter structure 
(ERMES) can be bypassed by point mutations in the vacuolar protein Vps13, or 
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by overexpression of the mitochondrial Mdm10 complementing protein 1 (Mcp1). 
However, the mechanism by which this bypass support lipid homeostasis has 
remained unclear. In this work, I analyzed the membrane topology of Mcp1. My 
findings revealed that Mcp1 functions as a recruiter of Vps13 to mitochondria and 
promotes formation of vacuole-mitochondria MCS. I demonstrated that the N-
terminal region of Mcp1 is exposed to the cytosol and mediates the recruitment 
of Vps13, thus establishing a functional mitochondria-vacuole MCS that 
compensate for the loss of ERMES.              
 Finally, in a third project of my doctoral studies I investigated the 
relationship between the ERMES complex and the coenzyme Q6 (CoQ6) 
biosynthesis system. I observed that supplementation of yeast cells lacking 
functional ERMES with CoQ6 could rescue the growth retardation and the altered 
mitochondrial morphology of these mutated cells. Based on additional results 
from collaborating groups, we suggest that the ERMES complex coordinates 
coenzyme Q biosynthesis.   
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5. Introduction 
5.1 Origin, structure, and function of mitochondria 
 
Mitochondria are essential organelles of most eukaryotic cells. They 
evolved from a subgroup of aerobic bacteria that were incorporated by an 
anaerobic ancestor over 1.5 billion years ago, the so-called endosymbiotic event 
(Gray, 2012). Like Gram-negative bacteria, mitochondria are enclosed by two 
membranes that divide the organelle into four subcompartments. The 
mitochondrial outer membrane (MOM) separates the organelle from the 
surrounding cytosol, while the mitochondrial inner membrane (MIM) separates 
the intermembrane space (IMS) from the innermost subcompartment, the matrix.  
Each mitochondrial subcompartment contains a specific group of proteins with 
specialized functions. The MOM contains several proteins that play roles in 
mitochondrial fusion, fission, biogenesis, inheritance, and morphology. The MIM 
contains a high amount of proteins which are mostly subunits of the respiratory 
chain complexes or carrier proteins involved in metabolites transport across the 
membrane (Gutman et al., 1993; Kühlbrandt, 2015). The vast majority of 
mitochondrial proteins (>99%) are nuclear-encoded and are synthesized as 
precursors on cytosolic ribosomes before their import and assembly into 
mitochondria. A small number of proteins (8 in yeast and 13 in humans) are 
encoded by the mitochondrial genome (Neupert and Herrmann, 2007; Sickmann 
et al., 2003). These group of proteins, which are subunits of the respiratory chain 
complexes, are inserted into the MIM in a process mediated by  Oxa1, a 
conserved membrane protein (Krüger et al., 2012; Stiller et al., 2016).
 Mitochondria are highly dynamic organelles that form a branched and 
tubular network. This morphology is regulated by fusion and fission processes 
which ascertain mitochondrial DNA (mtDNA) stability and the bioenergetics 
function of the organelle (Hoffmann and Avers, 1973; Okamoto and Shaw, 2005; 
Westermann, 2010). 
Mitochondria fulfil crucial roles in cellular bioenergetics, apoptosis, and 
metabolism of amino acids, lipids, and heme. One of the main metabolic 
pathways that takes place inside the organelle is the tricarboxylic acid (TCA) 
cycle, which provides reducing equivalents to the respiratory chain complexes 
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through the oxidation of acetyl-CoA (Lill et al., 1999; Scheffler, 2001). 
Furthermore, mitochondria are also involved in cellular signalling and aging 
(Bratic and Larsson, 2013; Hockenbery et al., 1990; Pizzo and Pozzan, 2007).
 Taken together, all these important functions explain why mitochondrial 
dysfunctions can result in a variety of pathologic scenarios and have been 
implicated in many disorders such as diabetes mellitus, carcinogenesis, and 
neurodegenerative diseases (Antunes et al., 2014; Beal, 2005; Enns, 2003). 
 
5.2 Homeostasis of mitochondrial lipids 
 
To properly carry out all their functions, mitochondria have to maintain their 
own unique protein and lipid composition. Although phospholipids (PLs) comprise 
the most abundant lipid class of mitochondrial membranes, sphingolipids and 
sterols can also be found within these structures. Phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), phosphatidylinositol (PI) and CL constitute the 
most abundant PLs in yeast mitochondria (Horvath and Daum, 2013; Zinser et 
al., 1991). 
Given the nearly absent variation in the mitochondrial PL composition 
among different organisms or cells type, alterations in PL content have been 
linked to several pathological disorders such as heart failure, neurodegenerative 
diseases, atherosclerosis, and Barth syndrome (Chicco and Sparagna, 2007; 
Fruhwirth et al., 2007; Schlame and Ren, 2006). The maintenance of appropriate 
lipid composition relies on the capability of mitochondria to autonomously 
synthesize some phospholipids like CL, PE and phosphatidylglycerol (PG) from 
their precursors. However, other lipids, such as phosphatidic acid (PA), PI, 
phosphatidylserine (PS), and PC, are synthesized in other organelles, specifically 
in the endoplasmic reticulum (ER), from where they have to be transported to 
mitochondria (Daum and Vance, 1997; Horvath and Daum, 2013) (Figure T1). 
 
Introduction 
 
11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure T1: Phospholipid synthesis and lipid transport between ER and mitochondria. PA 
serves as universal phospholipid precursor, which is synthesized in the ER. Therefore, 
it has to be transported to mitochondria where it is required for the synthesis of PG and 
CL. PI and PS are also primarily made from PA but in the ER. Newly synthesized PS is 
transported from the ER to mitochondria and subsequently decarboxylated to PE. The 
latter has to be exported from mitochondria to allow its conversion to PC in the ER.  
 
Among the mitochondrial lipids, CL constitutes the signature dimeric PL of 
this organelle. It exhibits a specific fatty acid composition compared to other PLs, 
since it predominantly harbours unsaturated fatty acyl chains (Schlame et al., 
2000). Hence, in contrast to other PLs, newly synthesized CL must undergo acyl 
chain remodeling which replaces the pre-existing fatty acids with new ones that 
are organism and tissue specific (Schlame et al., 2005). This maturation is crucial 
for mitochondrial functionality. Indeed, defective CL remodeling is associated with 
a number of clinical disorders including BTHS, a rare X-linked disease 
characterized by skeletal myopathy, cardiomyopathy, and, in some cases, 
neutropenia (Barth et al., 1999).
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5.2.1 ERMES complex  
 
As previously described, PL biosynthesis in yeast is mainly taking place in 
the ER and mitochondria. Since the latter are not involved in vesicular lipid 
exchange, the transfer of lipids between mitochondria and other cellular 
compartments is promoted by close contacts of the membranes and via protein 
complexes that form bridges between the organelles involved (Kornmann et al., 
2009; Tamura et al., 2014). Of note, already more than 20 years ago, lipid 
synthesizing enzymes were detected in mitochondria-associated membranes 
(MAMs) of the ER, implying a close connection of lipid synthesis and transport 
between the two organelles (Dimmer and Rapaport, 2017; Vance, 1990; Voelker, 
1990). 
In the baker’s yeast Saccharomyces cerevisiae, a tether termed ERMES 
was identified as a protein complex that participates in lipid transport at contact 
sites between ER and mitochondria (Kornmann et al., 2009). ERMES, whose 
orthologues have been identified only in fungi, is composed of four subunits: two 
mitochondrial subunits (Mdm10 and Mdm34) embedded in the MOM, a subunit 
(Mmm1) anchored to the ER membrane and a soluble subunit (Mdm12). Loss of 
individual components of the ERMES complex results in reduced mitochondrial 
levels of PE and CL, suggesting the crucial role of this complex in PL exchange 
between ER and mitochondria (Kornmann et al., 2009; Osman et al., 2009). 
 Interestingly, subunits of ERMES were first identified due to their effect on 
mitochondrial morphology. Furthermore, ERMES loss triggers many other 
phenotypes such as a disturbed mitochondrial inheritance and an increased 
tendency to lose the mtDNA (Kornmann et al., 2009; Murley et al., 2013; Okamoto 
and Shaw, 2005). In addition, protein assembly in the MOM, mitophagy, and 
respiratory chain complexes assembly are impaired in the absence of ERMES 
(Klecker et al., 2014; Tan et al., 2013). 
Despite the pivotal role in mitochondrial biogenesis, cells lacking functional 
ERMES are still viable and certain trafficking of lipids to and from mitochondria 
yet occurs  (Kornmann et al., 2009; Nguyen et al., 2012; Voss et al., 2012). This 
implies the existence of alternative pathways for lipid exchange of mitochondria 
with either the ER or other organelles. Although the most prominent function of 
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the ERMES complex is its involvement in lipid homeostasis, there are still many 
open questions regarding its function to be addressed. Specifically, it is unclear 
whether other molecules are being transported via this ER- mitochondria 
contacts, and if additional proteins play a role in that interplay. 
 
5.2.2 ERMES-alternative pathways 
 
Recent studies have identified alternative tether complexes involved in 
lipid transport between mitochondria and other cellular organelles. The ER 
membrane protein complex (EMC) was identified as a second ER-mitochondria 
tether structure that is involved in the transport of PS from the ER to mitochondria 
(Lahiri et al., 2014). In addition, the vacuole and mitochondria patches 
(vCLAMPs) form contact sites between the mitochondria and the vacuole, 
mediated by the vacuolar factor Vps39. Interestingly, the simultaneous loss of 
ERMES and vCLAMPs is lethal in yeast cells, suggesting that the pathways are 
redundant. It was also shown that contact sites are highly dynamic and that the 
elimination of one leads to the expansion of the other (Elbaz-Alon et al., 2014; 
Honscher et al., 2014).       
 Although the ERMES complex is involved in numerous mitochondrial 
functions, the existence of ERMES-independent pathways for interorganellar lipid 
exchange implies the existence of additional players in this context. To obtain 
further insight into these pathways, a multi-copy suppressor screen of the growth 
phenotype resulting from the deletion of the ERMES subunit Mdm10 was 
employed. Three mitochondrial proteins, named Mcp1-3 have been identified 
(Sinzel et al., 2016; Tan et al., 2013). Despite the fact that all three proteins 
restore defects resulting from loss of ERMES, there is no physical interaction of 
Mcp1, Mcp2 or Mcp3 with any component of the ERMES complex. This is likely 
due to the involvement of these proteins in a pathway independent of the ERMES 
complex.          
  In a recent work, to which I contributed, a physical interaction between 
Mcp1 and the vacuolar protein Vps13 was reported (John Peter et al., 2017). 
Vps13 was previously described to contribute to a bypass pathway of ERMES 
function via its activity at vCLAMPs (Lang et al., 2015; Park et al., 2016). The 
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recent finding suggests that Mcp1 and Vps13 could cooperate in recruitment of 
lipid transport proteins serving as effectors of vCLAMPs. In this model, Mcp1 
would be required to recruit Vps13 to the proximity of mitochondria, through 
expansion of contact sites between mitochondria and the vacuole, which are 
mediated by Vps39 and the vacuolar Rab GTPase Ypt7 (Elbaz-Alon et al., 2014; 
John Peter et al., 2017). Although Mcp1 has no orthologues in higher eukaryotes, 
its sequence harbours four conserved residues that are typical for an 
uncharacterized protein family (PF07950 family) of succinate dehydrogenases in 
Gram-positive bacteria. Mutations of these residues greatly decreased the 
activity of Mcp1 in the ERMES-bypass pathway albeit they did not totally abolish 
it (John Peter et al., 2017).        
 In contrast to Mcp1, Mcp2 has homologues in higher eukaryotes, the 
human ADCK1 or ADCK5, predicted kinases of the so-called AarF domain- 
containing kinases (ADCKs) family, with unknown function. Another member of 
the family, ADCK3 plays a role in coenzyme Q biosynthesis (Xie et al., 2011). To 
date, there is no evidence for the involvement of Mcp3 in lipid metabolism. 
Interestingly, there is a conserved glycine motif between Mcp3 and the 
mammalian mitochondrial outer membrane receptor for hypoxia-induced 
mitophagy FUNDC1 (Liu et al., 2012). The mammalian protein was reported to 
be enriched at the MAM where it promotes mitochondrial fission in a DRP1-
dependent manner (Wu et al., 2016).  Considering the impaired mitophagy of 
yeast cells lacking ERMES (Bockler and Westermann, 2014),  one might 
speculate that Mcp3 can play a role in mitophagy.   
 Taken together, the molecular functions of Mcp1, Mcp2 and Mcp3 are 
currently unknown. The recent observations favour the hypothesis that Mcp1 acts 
in the same pathway together with Vps13 i.e. in tethering vacuole and 
mitochondria. The identification of additional pathways that can bypass ERMES 
might provide a more detailed understanding of the mechanism of interorganellar 
lipid transport in higher eukaryotes (van Meer et al., 2008).  
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5.3 Mitochondrial respiration and oxidative phosphorylation 
 
Through the process of OXPHOS in the MIM, mitochondria are the main 
producers of ATP in eukaryotic cells. This process is facilitated by the electron 
flow between the respiratory chain complexes. This in turn is coupled to the 
generation of a proton gradient across the MIM, which ultimately leads to ATP 
production. The OXPHOS system is powered by reducing equivalents in the form 
of NADH or FADH2, which are generated in different metabolic pathways such as 
glycolysis, fatty acid oxidation or the TCA cycle. The respiratory chain is 
organized in five multi-subunit enzyme complexes termed NADH dehydrogenase 
(complex I), succinate dehydrogenase (complex II), cytochrome C reductase 
(complex III), cytochrome C oxidase (complex IV) and F1F0-ATP synthase 
(complex V) (Boekema and Braun, 2007).      
 Complex I catalyses the oxidation of NADH to NAD+, transfers the 
liberated electrons to coenzyme Q (also known as ubiquinone), and releases four 
protons into the IMS. In yeast, a complex formed by Nde1, Nde2, and Ndi1 
substitutes for complex I. In this system, electrons are transferred from NADH to 
CoQ but without the transport of protons into the IMS (Matus‐Ortega et al., 2015). 
Complex II catalyses the oxidation of succinate to fumarate in the TCA cycle. The 
resulting electrons are passed to CoQ, which acts as an electron carrier, 
mediating electron transfer to complex III. While oxidizing CoQ and in turn 
reducing cytochrome C, complex III releases four protons into the IMS. Complex 
IV is the last protein of the mitochondrial electron transport chain. This complex 
accepts electrons from cytochrome C and pumps four additional protons into the 
IMS. Finally, complex IV forms water from reduced oxygen molecules. The 
combined transfer of protons by the various respiratory chain complexes to the 
IMS generates an electrochemical gradient across the MIM. Ultimately, the proton 
gradient is used by complex V to produce ATP (Boekema and Braun, 2007; 
Kühlbrandt, 2015).  
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5.3.1 Coenzyme Q biosynthesis       
  
CoQ is an essential lipid that plays a vital role in mitochondrial respiratory 
electron transfer and is also known as an antioxidant molecule (Genova and 
Lenaz, 2011). In S. cerevisiae, CoQ biosynthesis takes place on the matrix side 
of the MIM and yeast mutants lacking CoQ display a growth defect on non-
fermentable carbon sources due to the respiration deficit (Awad et al., 2018; 
Bentinger et al., 2010). CoQ biosynthesis is mediated in yeast by the so-called 
CoQ synthome (or Complex Q in higher eukaryotes), which is a multisubunit 
complex that produces  several Coq intermediates and CoQ itself (Coq3-Coq9 
and Coq11) (Allan et al., 2015; Marbois et al., 2009). Studies in the last years, 
using human homologues of yeast proteins have started to disclose details of the 
CoQ biosynthesis pathway (Allan et al., 2015; He et al., 2015; Marbois et al., 
2010). In yeast, the CoQ6 precursors are derived from the isoprene biosynthetic 
pathway at the ER (Tran and Clarke, 2007).     
 Considering the known potential of contact sites to transfer molecules and 
metabolites between organelles (Eisenberg-Bord et al., 2016), it is tempting to 
postulate an additional role of ER-mitochondria contact sites in promoting the 
transport of CoQ6 and its intermediates or precursors between the two 
organelles. Indeed, it has been shown that loss of the mammalian 
mitochondrial protein mitofusin 2 (MFN2), which was reported to mediate ER-
mitochondria contacts (de Brito and Scorrano, 2008; Merkwirth and Langer, 
2008), results in impaired mitochondrial respiration due to decreased CoQ levels 
(Mourier et al., 2015). Furthermore, recent observations point to a possible role 
of ERMES in biosynthesis of CoQ. A human homologue of the mdm10∆ 
suppressor Mcp2 is ADCK3. This protein in turn belongs to the ADCK family, 
which also comprises COQ8A, an ATPase that facilitates both the assembly of 
the CoQ synthome and de novo biosynthesis of CoQ (Reidenbach et al., 2018).  
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5.4 Cardiolipin (CL) is required for many mitochondrial functions
  
In order to increase the efficiency of the electron transport, the 
mitochondrial respiratory complexes are stably interacting with each other and 
together form the so-called supercomplexes. The lipid composition of the MIM 
has an impact on the OXPHOS efficiency since it can affect supercomplexes 
assembly. It has been reported that CL is tightly associated with mitochondrial 
respiratory chain complexes and that its presence is required for efficient 
mitochondrial bioenergetics (Lange et al., 2001; Schlame et al., 2000; Zhang et 
al., 2002). Indeed, yeast cells lacking CL have impaired respiratory growth and 
decreased complex III and complex IV activities. These phenotypes cannot be 
complemented by any other PL or non-remodeled CL species (Baile et al., 2014; 
Hoffmann et al., 1994; Jiang et al., 2000; Pfeiffer et al., 2003).  
 In addition to its key role in maintenance of mitochondrial OXPHOS, CL 
has also been implicated in the biogenesis of MOM proteins (Gebert et al., 2009; 
Sauerwald et al., 2015). Moreover, CL supports the molecular architecture and 
fluidity of the membrane and several proteins, such as cytochrome C, need an 
electrostatic interaction with CL for their binding to the MIM. Consequently, 
alterations in CL can trigger downstream events in apoptosis such as the release 
of cytochrome C and other pro-apoptotic factors into the cytosol (Chicco and 
Sparagna, 2007; Iverson et al., 2004; Wenz et al., 2009). The various roles of CL 
in mitochondrial functions are conserved in all eukaryotes. Alterations either in 
the content or structure of CL represent a hallmark in a variety of diseases 
characterized by mitochondrial dysfunction (Chicco and Sparagna, 2007; 
Claypool and Koehler, 2012). 
 
5.4.1 Relevance of CL remodeling to Barth Syndrome 
 
While three CL remodeling pathways have been identified in higher 
eukaryotes, Taz1 is the only transacylase that mediates the remodeling process 
in yeast (Claypool and Koehler, 2012) (Figure T2). The importance of this 
process is exemplified by the loss of functional tafazzin, the human homologue 
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of Taz1, that leads to the life-threatening genetic disorder BTHS (Barth et al., 
1999; Whited et al., 2013).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure T2: Schematic representation of CL remodeling in yeast. Nascent CL is 
deacylated by the phospholipase Cld1 forming MLCL, which is reacylated by Taz1 to 
form remodeled CL containing more unsaturated acyl chains (depicted in bold). 
 
An absence of Taz1 results in a decrease of the cellular amounts of CL, an 
accumulation of monolyso-CL (MLCL), and aberrant CL species (Gu et al., 2004; 
Schlame et al., 2002). Similar alterations were also observed in fibroblasts and 
platelets obtained from patients with BTHS or animal models (Schlame et al., 
2002; Valianpour et al., 2002; Vreken et al., 2000). Interestingly, the increased 
MLCL/CL ratio has been pointed out as the cause of BTHS. These findings have 
been supported by the rescue of the phenotypes observed in the yeast taz1∆ 
BTHS model by deleting the enzyme responsible for CL deacylation (Baile et al., 
2014; Ye et al., 2014). As a result of the compromised CL levels, yeast 
mitochondria lacking Taz1 exhibit a decreased membrane potential and 
increased proton leakage (Baile et al., 2014; Ma et al., 2004). Abolishing the 
proton gradient across the MIM enhances the production of reactive oxygen 
species (ROS) which leads to oxidative damages (Chen et al., 2008). In BTHS, 
tafazzin mutations induce defective CL remodeling, which compromises the ATP 
production through oxidation of the respiratory intermediate NADH, leading to a 
decrease in the NAD+/NADH ratio (Gonzalvez et al., 2013). As a consequence of 
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NADH accumulation, metabolic dysfunctions, such as inhibition of TCA cycle 
enzymes that use NAD+ as a substrate, take place and the TCA cycle activity 
decreases (Ikon and Ryan, 2017; Vatrinet et al., 2017). Although tafazzin 
mutations have been largely implicated in BTHS, the precise role and the 
involvement of this protein in the pathomechanism of the disease remain unclear. 
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6. Research objectives 
 
Phospholipids are essential structural components of all eukaryotes 
membranes. Notwithstanding their importance and wide distribution, the 
processes in which they take part remain ill defined. Among these processes is 
the lipid transport between and within organelles. Despite the increasing number 
of proteins identified to be involved in lipid exchange, the detailed mechanism still 
has to be discovered. In this thesis, I intended to obtain a deeper understanding 
of the processes that ensure mitochondrial phospholipid homeostasis. To this 
end, I focused on three main tasks: 
1. To better understand the pathways of lipid transport, I investigated the 
process by which Mcp1 can rescue the growth phenotype of cells lacking the 
ERMES subunit Mdm10.  
2. Despite extensive research on BTHS, the molecular basis of the disease 
remains uncharacterized. To shed light on the pathomechanism of this disease, 
which is caused by defective CL remodeling, I used yeast cells as a model system 
and aimed at finding multicopy suppressors of the growth retardation resulting 
from the absence of the CL modulating protein, Taz1.  
3. To obtain a full spectrum of the functions of ERMES, I asked whether 
this complex is involved in regulating CoQ6 biosynthesis in yeast cells. 
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7. Summary of the results 
Unless otherwise specified all the figure references are referring to the 
figures in the articles corresponding to the current section. 
7.1. Vps13-Mcp1 interact at vacuole-mitochondria interfaces and 
bypass ER-mitochondria contact sites (Peter et al., Journal of 
Cell Biology, 2017) 
 
Our knowledge about ER-mitochondria contact sites is very limited. To 
date, the yeast ERMES complex was reported to be involved in many vital 
processes such as lipid transport, biogenesis of OM proteins, maintenance of 
mitochondrial DNA, and mitochondrial morphology and respiration (Kornmann et 
al., 2009; Sinzel et al., 2016; Tan et al., 2013). Yet, the main function of the 
complex or of its subunits is unknown.        
To address this issue, a multi-copy suppressors screen of the growth 
defects of mdm10Δ cells was performed. Among other high copy suppressors of 
mdm10Δ cells, Mcp1 was identified (Tan et al., 2013). 
Although the double deletion of MCP1 and ERMES components is 
synthetic lethal, the lack of Mcp1 alone does not lead to any defect in 
mitochondrial function or to any clear impairment in the behaviour of yeast cells 
(Tan et al., 2013). The absence of such clear phenotypes of the mcp1Δ deletion 
strain makes it difficult to study the function of Mcp1.  
Such observations are suggestive that Mcp1 and ERMES might function 
in redundant parallel pathways. In fact, it has been recently shown that a vacuolar 
protein Vps13 acts as an ERMES suppressor probably by enhancing the 
formation of vCLAMPs (Lang et al., 2015). Additionally, Mcp1 was observed to 
be required for this Vps13 suppressor function, behaving as Vps39, a known 
component of vCLAMPs (Lang et al., 2015).      
 According to these recent findings, Mcp1 might function in the same 
pathway as Vps13 and Vps39. Thus, we aimed to investigate the ERMES-
independent pathway in which Mcp1 may be involved. To obtain further insights 
into the molecular function of Mcp1, I searched for potential physical interaction 
partners of this mitochondrial protein.       
 To that end, I employed immunoprecipitation experiments assays using 
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lysates from mcp1Δ yeast cells expressing plasmid-encoded HA-tagged Mcp1. 
Bound proteins were analyzed by immunodecoration and gel staining followed by 
mass spectrometry (MS). Specifically, MS analysis revealed that a ~370 kDa 
band corresponds to Vps13 whereas another band migrating at ~35 kDa 
represents HA-Mcp1 itself (Figure T3, data not included in the manuscript). 
Reciprocal immunoprecipitation experiments have been performed with tagged 
Vps13. However, it was not possible to confirm this interaction, probably due to 
technical problems. I anticipated that the fact that Vps13 is the fifth largest protein 
in the yeast proteome and dynamically localizes to different membrane contact 
sites (vCLAMPs and NVJs), combined with an apparent low steady-state levels 
of Mcp1 might be responsible for the difficult detection of this interaction. 
 
 
Figure T3: Mcp1 interacts with Vps13. 
Whole cell lysate from mcp1Δ cells transformed with an empty plasmid (Ø) or with a 
plasmid encoding Mcp1-HA were subjected to anti-HA immunoprecipitation and 
analyzed by SDS-PAGE and silver staining. The arrows depict the retrieved bands which 
were analyzed by LC-MS/MS (#1, Vps13; #2, Mcp1-HA).  
 
Bioinformatics analysis of Mcp1’s sequence predicts a total of five 
transmembrane domains. However, Mcp1 topology has not been experimentally 
assessed and such knowledge is fundamental to understand how the Mcp1-
Vps13 interaction might occur. In order to obtain further insight into the topology 
of Mcp1, I treated mitochondria isolated from cells overexpressing either Mcp1 or 
its C-terminally HA-tagged version with proteinase K (PK). Proteolytic fragments 
were detected by Western blotting with either an anti-HA antibody to detect the 
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C-terminal region of the protein or an antibody raised against the N-terminal 
domain of Mcp1 (Fig. 3B). Interestingly, using low concentrations of PK and both 
versions of Mcp1, a proteolytic fragment of ~20 kDa was identified with the anti-
Mcp1 antibody. These findings suggest cleavage at the level of loop 2 and that 
the N-terminal domain is exposed to the cytosol (Fig. 3B and C). Of note, at higher 
PK concentrations, a proteolytic fragment of ~ 12 kDa is observed (Fig. 3B, 
fragment II). According to its size, this fragment corresponds to a cleavage 
immediately after the second transmembrane domain, excluding loop 2 (Fig. 3C).
 Surprisingly, the N-terminal fragment remained protease resistant. This 
indicates that either the N-terminal is tightly folded or the epitope was too close 
to the membrane. In accordance with this, the localization of the HA-tag at the C-
terminal of Mcp1 and the detection of Mcp1-HA fragments even at high 
concentrations of PK further confirm the N-out, C-in topology. Accordingly, at 
different concentrations of externally added PK, it was possible to detect with the 
anti-HA antibody a double fragment of ~ 17 kDa in size (Fig. 3B, fragment IIIa 
and IIIb). The detected fragments probably correspond to a fragment containing 
the transmembrane domains three to five with different cleavage levels in loop 2 
(Fig. 3C, fragment III).        
 Based on the aforementioned results I suggest a Mcp1 topology where the 
N-terminal domain is exposed to the cytosol whereas the C-terminal is facing the 
intermembrane space. Such a topology suggests that the N-terminal of Mcp1 (aa 
1-61) and/or loop 2 (aa 122-173) could potentially interact with Vps13. Although 
loop 4 is equally exposed to the cytosol, it might be too short to act as a binding 
site.          
 Homology analysis based on the sequence of Mcp1 proposed similarity to 
quinol fumarate reductase diheme cytochrome B subunit C of the 
proteobacterium Wolinella succinogenes. Thus, suggesting that beyond the 
recruitment of Vps13, Mcp1 might have an additional role as a heme binding 
protein.           
 To investigate whether heme binding is an important feature of Mcp1, the 
likely heme-binding histidines and other residues that are conserved among 
Mcp1 and other members of an uncharacterized protein family (PF07950 family) 
were mutated to the neutral amino acid alanine. Next, in collaboration with the 
Kormann’s group, we addressed the capacity of the Mcp1 mutants to rescue the 
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growth defects of ERMES mutants and to recruit Vps13 to mitochondria (Fig. 4E-
F). In fact, mutating the presumptive heme-binding domains histidine residues 
(H187A and H237A) led to a lost rescue of the ERMES growth defects (Fig. 4E), 
independently of the ability to recruit Vps13 to mitochondria (Fig. 4F). While 
mutating other conserved residues (P195A and G241A) resulted on variable 
effects on ERMES rescue but did not affect Vps13 recruitment (Fig. 4E-F).  
Collectively, the conserved presumptive heme-binding domains in Mcp1 
appear to be essential for the rescue effect of the growth defects of ERMES 
mutants but do not appear to be related to Vps13-Mcp1 interaction on 
mitochondria. 
 
7.2 Overexpression of branched-chain amino acid 
aminotransferases rescues the growth defects of cells lacking 
the Barth Syndrome related gene TAZ1 (Antunes et al., Journal 
of Molecular Medicine, 2018) 
Tafazzin is a mitochondrial protein involved in the metabolism of CL, 
functioning as a phospholipid-lysophospholipid transacylase. Mutations in the 
tafazzin gene are associated with Barth syndrome (BTHS). BTHS is a rare X-
linked disease characterized by skeletal myopathy and cardiomyopathy, and in 
some cases neutropenia. The tafazzin gene is highly conserved from yeast to 
human. Deletion of the yeast orthologue TAZ1 results in a decrease in the total 
cellular amounts of CL, increased levels of monolyso-CL (MLCL), and 
compromised functions of mitochondria (Ye et al. 2014; Baile et al. 2014). Similar 
alterations were also observed in fibroblasts and platelets obtained from either 
patients with BTHS or animal models (Valianpour et al. 2002; Vreken et al. 2000; 
Schlame et al. 2002). Despite extensive research, the molecular basis of BTHS 
remains uncharacterized.        
 To gain insight into the pathomechanism of BTHS, I performed a screen 
for multi-copy suppressors of the taz1Δ growth defect using a yeast genomic 
library cloned into a high copy number (2μ) yeast expression vector. The deletion 
of TAZ1 leads to a strong growth defect on synthetic medium containing ethanol 
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as the sole carbon source (SE) (Fig. 1A). Initially, I verified that the growth defect 
can be reversed upon overexpression of Taz1 from a plasmid (Fig. 1A), 
suggesting that the absence of Taz1 is the primary reason for this defect.  
 To ensure complete coverage of all yeast genes, I screened 55,000 
colonies and identified genomic segments harbouring CRG1, COX24, HMX1, 
and BAT1 as suppressors of taz1Δ growth defect. However, among these 
candidates only BAT1 genomically overexpression in taz1Δ cells could rescue 
the taz1Δ growth defect (Fig. 1B-D). BAT1 encodes for a mitochondrial branched-
chain amino acid transaminase (Kispal et al., 1996). Yeast cells contain in 
addition to Bat1 also its cytosolic homologous protein Bat2.  
 Therefore, I asked whether the cytosolic branched-chain amino acid 
transaminase isoform also has a growth defect rescue capacity, similarly to its 
mitochondrial homologue. Using complementation growth tests, I observed that 
overexpression of BAT2 could also complement the impaired growth of taz1Δ 
cells, although the rescue conferred by BAT2 was weaker than that observed with 
BAT1 (Fig. 1D). Such a difference could result from different protein expression 
among the isoforms or simply from their diverse localisations and/or function. To 
investigate whether the observed effects could be explained by altered protein 
expression, I performed western blotting analysis and verified that indeed Bat1 
and Bat2 are detected in higher levels in the overexpressing strains. Given the 
high sequence homology between Bat1 and Bat2, the antibody raised against 
Bat1 also recognises Bat2. Hence, it is difficult to draw a conclusion on whether 
Bat1 and Bat2 are expressed at similar levels. Notably, Bat1 expression levels 
are decreased in bat2∆ cells (Fig. S1) This observation might be explained by the 
synergetic function of these dual distributed enzymes.    
 To test whether the observed compensation can be also extended to the 
loss of CL, I analyzed the growth of cells deficient for CL upon the deletion of key 
enzymes in its biosynthesis pathway, GEP4 and CRD1. BCATs overexpression 
did not rescue of the growth defects of cells lacking any of the CL biosynthetic 
enzymes (Fig. 1E). These results indicate that enhanced metabolism of amino 
acids can compensate for defects specifically related to CL remodeling but not to 
its absence.          
 In accordance with  the stabilizing role of CL in the electron transport chain 
supercomplexes, mitochondria lacking yeast Tafazzin display a defective 
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assembly of the respiratory chain complexes (Bazan et al., 2013; McKenzie et 
al., 2006; Zhang et al., 2005) and consequently reduced membrane potential 
(ΔΨ) (Brandner et al., 2005). To examine the effect of BCATs overexpression on 
these mitochondrial defects of taz1Δ cells, I performed blue native (BN)-PAGE 
analysis. Importantly, this analysis showed that genomically overexpressed BAT1 
or BAT2 did not affect the complexes stability (Fig. 2A-B). Similarly, using the 
membrane potential-sensitive dye 3,3’-diprophylthiadicarbocyanine iodide 
(DiSC3(5)) I determined the ΔΨ of mitochondria isolated from taz1Δ cells 
overexpressing either BAT1 or BAT2, and did not observe any improvement upon 
such overexpression (Fig. 2C).       
 As a major consequence for the loss of the phospholipid-lysophospholipid 
transacylase function, mitochondria from taz1Δ cells exhibit a decrease in the 
amount of CL and accumulation of MLCL (Xu et al., 2016). Therefore, I decided 
to investigate the effect of BAT1/2 overexpression on taz1Δ mitochondrial PL 
profile. Hence, I performed thin layer chromatography (TLC). However, BAT1 or 
BAT2 overexpression in these cells did not rescue this altered PL profile (Fig. 
2D). This suggests that recovery of the mutant cells defective growth does not 
depend on a rescue of lipid homeostasis. In line with this notion, I further 
investigated the effect of BCATs on the steady state levels of various 
mitochondrial proteins residing in all sub-compartments of the organelle and 
found no alteration of the proteins levels upon BAT1/2 overexpression in taz1Δ 
cells (Fig. 2E).          
 Next, I sought to investigate whether amino acids metabolism is relevant 
for the growth deficit observed of cells lacking Taz1. Bat1/2 catalyze the 
conversion of branched-chain amino acids (BCAAs) and α-ketoglutarate into 
branched chain α-keto acids and glutamate. The products that result from BCATs 
activity are in turn used as TCA cycle substrates. To test the involvement of 
BCAAs on the taz1Δ cells growth defect, I analyzed by drop dilution assay the 
effect of supplementing SE medium with these amino acids. I observed a 
significantly improvement of the growth of the mutated cells upon valine 
supplementation (Fig. 3A). This enhancement is especially noticeable upon 
addition of an effective valine concentration of 6.4 mM (Fig. 3A). However, the 
addition of the two other BCAAs, leucine (Fig. S3A) or isoleucine (Fig. S3D) was 
unable to abrogate the observed growth deficit of taz1Δ cells. Similar to the 
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situation upon BCAAs supplementation, the overexpression in taz1Δ cells of the 
LEU2 gene, encoding a key enzyme in the biosynthesis pathway of leucine, did 
not improve the growth of these cells (Fig. S3B).   
 Since the BCATs enzymes can catalyze the conversion between keto 
acids and amino acids in both directions, I assessed the growth of taz1Δ cells 
when the corresponding keto acid form of leucine, alpha-ketoisocaproic acid 
(KIC), was supplemented to the medium. Nonetheless, the growth of the mutated 
cells did not improve upon its addition to the solid medium (Fig. S3C). 
Interestingly, previous studies have shown that amino acids supplemented in the 
medium can be used by the cells as carbon source, contributing to the cellular 
oxidative energy supply via the TCA cycle (Hothersall and Ahmed, 2013; Kiebish 
et al., 2013). Therefore, I wanted to investigate whether the supplementation with 
amino acids that are easily converted to TCA cycle substrates could rescue the 
defects of taz1Δ cells. To this end, the amino acids aspartate, glutamate or 
histidine were added to the ethanol-containing plates and the growth of the 
mutated cells was monitored. Of note, the impaired growth of taz1Δ cells was 
largely or partially rescued upon supplementation with aspartate or glutamate 
(Fig. 3B and D, respectively). Additionally, supplementing the mutant cells with 
either valine or aspartate did not alter the MLCL/CL ratio of mitochondria of taz1Δ 
cells (Fig. 3C). Interestingly, addition of histidine to the medium could fully restore 
the growth deficit of taz1Δ cells (Fig. 3E). These findings demonstrate that Bat1/2-
mediated rescue of Taz1-depleted cells might be explained by elevated cellular 
levels of some amino acids. Since I cannot exclude the impaired transport of 
amino acids from the vacuole to the cytosol as the cause of taz1Δ cells growth 
defect, I investigate whether the overexpression of two vacuolar amino acid 
transporters AVT1 and AVT4 in the mutated cells could rescue such impaired 
growth. In yeast cells, under nutrient-rich growth, approximately 50% of the total 
amino acids are stored in the vacuole (Kawano-Kawada et al., 2018). Therefore, 
in conditions such as under nutrient starvation, these amino acids should be 
rapidly excreted to the cytosol in order to be used for de novo protein synthesis. 
However, overexpression of both amino acid transporters did not improve the 
growth of taz1Δ cells (Fig. 3F). This demonstrates that elevated amino acids 
transport is not sufficient or related to, the growth rescue guaranteed by certain 
amino acids supplementation in the mutant cells.     
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 Next, I sought to investigate whether the direct supplementation of the SE 
media with TCA cycle metabolites could improve the growth of cells lacking Taz1. 
Surprisingly, I did not observe any rescue of the growth defect in those cells (Fig. 
S4A-E). These findings might suggest that the TCA-cycle products prevenient 
from BCATs overexpression are not sufficient to improve the growth defect of 
taz1Δ cells and that some other BCATs-related metabolites might be involved in 
this scenario.       
In conclusion, my findings indicate that the overexpression of BCATs and 
enhanced metabolism of certain amino acids like valine have an important and 
disease relevant role in cells lacking Taz1 function. 
 
7.3 ER-Mitochondria Encounter Structure (ERMES) 
coordinates coenzyme Q biosynthesis (Eisenberg-Bord et al., 
Contact, 2018, in revision) 
 CoQ is a redox lipophilic molecule responsible for electron transfer 
between the mitochondrial respiratory chain complexes whose deficiency causes 
pathologic disorders. To date, comprehensive information on CoQ biosynthesis 
and/or relevance is still missing. Biosynthesis of CoQ is facilitated by the CoQ 
synthome consisting of several COQ gene products, CoQ itself, and CoQ 
intermediates. The above-mentioned process is not completely characterized 
and several players with unclear molecular functions remain unidentified (Allan 
et al., 2015; Awad et al., 2018).        
 In S. cerevisiae, CoQ biosynthesis takes place in the mitochondria matrix 
and yeast CoQ mutants display a growth defect on non-fermentable carbon 
sources due to the respiration deficit (Kawamukai, 2016). Although some human 
Coq deficiencies can be relieved upon CoQ dietary supplementation, the uptake 
and incorporation of this highly hydrophobic molecule is mostly ineffective 
(Hernández-Camacho et al., 2018).     
 Interestingly, a study in yeast has shown that CoQ mutants with defective 
production of CoQ6 (yeast CoQ) were rescued upon exogenously added CoQ6 
(Santos-Ocaña et al., 2002). This observation raises an intriguing possibility that 
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respiratory defective mutants might benefit from CoQ6 supplementation to their 
growth media.        
 Specifically, I asked whether exogenous addition of CoQ6 could rescue 
mitochondrial defects of ERMES mutant cells, such as yeast cells lacking the 
ERMES component MDM10. As previously mentioned, the deletion of MDM10 
leads to alterations in mitochondrial distribution, morphogenesis, and membrane 
potential. Mutant cells bear a strong growth defect on non-fermentable carbon 
sources (Sinzel et al., 2016; Tan et al., 2013).    
 Thus, I analyzed the effect of adding exogenously CoQ6 to mdm10Δ cells 
grown on non-fermentable carbon source. Growth analysis indicated that this 
supplementation did rescue the growth defect of MDM10 mutant suggesting that 
CoQ6 is indeed taken-up by mdm10Δ cells (Figure T4A below, data not included 
in the manuscript). Next, I analyzed the effect of exogenously added CoQ6 on 
the mitochondrial morphology defects that are observed upon loss of Mdm10. 
Fluorescence microscopy of mdm10Δ cells using a membrane potential 
independent dye (MitoTracker Green FM) revealed that CoQ6 supplemented to 
the growth media could rescue the mitochondrial morphology phenotype of these 
mutated cells, leading to a WT-like tubular network shape in 50% of the mutated 
cells (Figure T4B-C below, data not included in the manuscript). 
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Figure T4. Supplementation of YPE medium with CoQ6 affects mitochondrial 
morphogenesis of mdm10Δ cells. (A) Supplementation of YPE medium with CoQ6 
rescues the growth phenotype of mdm10Δ cells. The indicated cells were incubated in 
YPE liquid medium in the presence or absence of 30 μm exogenous CoQ6 and grown 
for 7 days. Growth was inferred (OD600) at the indicated times, Average values of six 
biological independent experiments are shown. (B) CoQ6 partially restores the 
mitochondria morphology defect in mdm10Δ cells. Cells described in (A) were grown to 
mid-logarithmic phase on YPE medium, stained with Mitotracker Green FM and then 
analyzed by fluorescence microscopy. Typical images from three biological independent 
experiments are shown (scale bar = 5 µm). (C) Analysis of the cells described in B. 
Average values with standard deviation bars of three biological independent experiments 
with at least 100 cells per experiment are shown. 
 
Taking together, ubiquinone can partially restore the mitochondria 
morphology defects of the ERMES mutant mdm10Δ.    
 Recently, analysis of human homologues of yeast proteins have started to 
disclose details of the CoQ biosynthesis pathway (Allan et al., 2015; He et al., 
2015; Marbois et al., 2010). Although CoQ is present in several cellular 
compartments, its biosynthesis takes place on the matrix side of the MIM (Tran 
and Clarke, 2007), which implies the need of CoQ’s exchange between cellular 
compartments. Due to the known potential of contact sites to transfer molecules 
and metabolites between two organelles (Eisenberg-Bord et al., 2016), it is 
tempting to speculate an additional role of ERMES in CoQ biosynthesis pathway. 
However, strong evidence for such connection is still to be obtain.   
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 In Eisenberg-Bord et al., (2018) it was shown that loss of ERMES leads to 
defective assembly of the CoQ synthome. To exclude the possibility that defective 
assembly of mitochondrial protein complexes is a general outcome of losing 
ERMES function, I performed BN-PAGE analysis of isolated mitochondria of 
mdm10∆ cells. This analysis showed that the monomer and dimer forms of 
ATPase synthase complex were not altered in the mutated cells (Figure T5 below, 
data to be included in the resubmitted manuscript).  
 
 
Figure T5. The assembly of the ATP synthase complex (complex V) is not altered 
in mitochondria lacking Mdm10. Mitochondria isolated from the indicated strains were 
lysed with 1% digitonin and subjected to a 6-14% BN-PAGE. Proteins were analyzed by 
immunodetection with antibodies against F1β (subunit of complex V). The monomeric 
and dimeric forms of complex V are indicated as V and V2, respectively.  
 
Collectively, the results described in Eisenberg-Bord et al. (2018) suggest 
that CoQ6 biosynthesis is coordinated with the ER-mitochondria contact site. 
Currently, the mechanism that mediates this process remains unclear.  
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8. Discussion 
8.1. Vps13-Mcp1 interact at vacuole-mitochondria interfaces 
and bypass ER-mitochondria contact sites 
 
The yeast mitochondrial outer membrane protein Mcp1 was identified as a 
high-copy suppressor of the growth phenotype of mdm10Δ cells. Overexpression 
of Mcp1 in mdm10Δ cells can restore typical ERMES defects (Tan et al., 2013). 
ERMES components are functionally involved in a broad spectrum of cellular 
processes, making it difficult to unravel the direct effect on lipid homeostasis. 
Taking advantage of the identified suppressors for ERMES defects, it is possible 
to study direct, and indirect effects derived from ERMES deletion (Dimmer and 
Rapaport, 2017; Lang et al., 2015; Tan et al., 2013).    
Mcp1 is not conserved in higher eukaryotes and loss of this protein does not 
result in any observable mitochondrial defect, suggesting that Mcp1 is part of an 
ERMES-independent pathway, which becomes crucial only when ERMES is 
deleted. In fact, it has been shown that the vacuolar protein Vps13 acts as an 
ERMES suppressor probably by enhancing the formation of mitochondria-
vacuolar contacts and that Mcp1 is required for the Vps13 dominant mutant 
suppression function (Lang et al., 2015). 
In this study, I could identify by mass spectrometry analysis the vacuolar 
protein Vps13 as one of Mcp1 interaction partners. This is in agreement with a 
previous report that Mcp1 and a Vps13 dominant mutant cooperate to bypass 
ERMES defects (Lang et al., 2015). In fact, co-immunoprecipitation experiments 
performed by my collaboration partners using Mcp1-HA and a GFP-tagged 
version of Vps13 with a point mutation (L1627S), which enhances the protein 
activity (Fig. 3A), could provide further evidence for the physical interaction 
between the mitochondrial Mcp1 protein and Vps13 (John Peter et al., 2017). 
Furthermore, I have demonstrated that the N-terminal of Mcp1 is exposed to 
the cytosol, whereas the C-terminal faces the IMS. Unexpectedly, the N-terminal 
fragment of the protein is protease resistant, which suggests that this domain is 
tightly folded. These results confirmed a Mcp1 topology where the N-terminal 
domain is exposed to the cytosol whereas the C-terminal region is facing the 
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intermembrane space. In fact, upon the expression of the N-terminal of Mcp1 (aa 
1-61) it could be observed a strong recruitment of Vps13 to mitochondria. These 
observations demonstrate that Mcp1 recruits Vps13 to mitochondria and its N-
terminal mediates the recruitment (John Peter et al., 2017).   
 It is surprising that even though Mcp1 is not conserved, we could 
demonstrate that the overexpression of the N-terminal fragment of Mcp1 was 
sufficient to recruit Vps13 to mitochondria. Of note, Mcp1 is predicted to fold into 
a heme-binding five-helix bundle, as found in quinol-fumarate reductases. On the 
same line, overexpressing Mcp1 variants that carry single mutations in the 
putative heme-binding domain failed to suppress the ERMES∆ growth defects 
without affecting the recruitment of Vps13 to mitochondria (John Peter et al., 
2017). Given the involvement of ERMES in lipid transport and the ability of Mcp1 
and Vps13 to induce the formation vacuole-mitochondria contact sites, it is 
plausible that both proteins are directly involved in lipid exchange.   
 Interestingly,  it has been recently reported the co-existence of another 
vacuole-mitochondria contact site, which is functionally distinct from the vCLAMP 
formed by Vps13 and Mcp1 (González Montoro et al., 2018). Accordingly, the 
vacuolar effector Vps39 binds the Rab Ypt7 and tether vacuoles with the TOM 
complex, via the Tom40 receptor, and thus establishes a vCLAMP. However, in 
contrast to the Vps13-Mcp1 complex, the afore-mentioned vCLAMP cannot 
function in the ERMES bypass pathway, which requires vesicular trafficking to 
the vacuole. This suggests that the vacuole might be the donor organelle for the 
lipid supplying pathway in which Vps13 functions (González Montoro et al., 2018). 
 Moreover, the structure of the N-terminal region of Vps13 (Vps13crystal; aa 
1-335) has recently been resolved and a hydrophobic cavity has been identified, 
which may form an extended lipid-binding surface formed by several Vps13crystal-
like domains present in the full-length Vps13 (Kumar et al., 2018). In the same 
study, it was demonstrated that the purified yeast N-terminal domain of Vps13 
binds approximately ten glycerophospholipids molecules, suggesting that Vps13 
might be able to accommodate and transfer several lipid molecules at once 
(Kumar et al., 2018).  
Moreover, recently a PxP motif, comprised of highly conserved prolines 
flanked by hydrophobic amino acids, was identified in the N-terminal domain of 
Mcp1. This motif was suggested to be the binding and recruitment site for Vps13. 
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This motif is not only involved in recruiting Vps13 to mitochondria but also to other 
membranes that can form vacuole contact sites (Bean et al., 2018). The cellular 
localization of Vps13 is mediated by the PxP motif present in its effectors. 
Specifically, the recruitment of Vps13 to mitochondria by Mcp1, to prespore 
membrane by Spo71, to endosomal and vacuolar membranes by Ypt35, and 
possibly more (Bean et al., 2018).   
 
In conclusion, our study revealed that Mcp1 functions in the same pathway 
as Vps13 and recruits the latter to mitochondria, mediating the association of 
vacuole to mitochondria. In contrast to Mcp1, Vps13 is highly conserved with four 
homologs in humans (Vps13A-D). This suggests that in metazoans probably 
another mitochondrial protein is functioning as Mcp1 by recruiting Vps13 to 
mitochondria. In a more general way, further studies are needed to determine 
whether there is a functional ERMES orthologue in higher eukaryotes or if its 
function is taken over by other inter-organelle contact sites. 
 
8.2. Overexpression of branched-chain amino acid 
aminotransferases rescues the growth defects of cells lacking 
the Barth Syndrome related gene TAZ1 
 
TAZ1 encodes the yeast orthologue of tafazzin whose mutations are the 
genetic origin of BTHS (Bione et al., 1996). Although the involvement of taffazin 
in this syndrome has been known for many years, it is still unclear why the 
absence of CL remodeling causes the associated clinical phenotypes. I sought to 
shed light on the cellular mechanisms that might be involved in the outcome of 
BTHS, using yeast as a model system. Yeast cells lacking Taz1 display a severe 
growth defect on synthetic medium using ethanol as the sole carbon source. 
Hence, I anticipated that the overexpression of a protein, which is relevant to this 
clinical disorder, would result in a rescue of the growth phenotype that could 
easily be screened for.        
  Interestingly, taz1Δ mutant cells grow normally on non-fermentable 
carbon sources like glycerol or acetate suggesting that compromised respiration 
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is not the primary defect of these cells. In fact, my collaboration partners 
demonstrated that these cells have increased respiration when compared to WT. 
These observations suggest that the higher oxygen consumption rate in taz1Δ 
mitochondria could be an attempt to compensate their compromised respiratory 
function (Fig. S2A). Interestingly, the overexpression of BAT1 or BAT2 in taz1Δ 
cells reverts the oxygen consumption to WT levels (Fig. S2A).  
 Furthermore, yeast mutants acquire an ethanol-tolerance dependent on 
their lipid composition and unsaturation degree (Chi and Arneborg, 1999). Thus, 
the sensitivity of the taz1Δ mutant to ethanol is most likely caused by the 
decreased CL levels and altered acyl composition of this crucial dimeric PL. 
Ethanol stress leads to inactivation of some mitochondrial enzymes upon 
increased production of reactive oxygen species (ROS) ultimately causing 
mitochondrial damage (Costa et al., 1997; Du and Takagi, 2007; Jimenez and 
Benitez, 1988). Indeed, the levels of carbonylation of proteins in taz1Δ cells 
grown in ethanol have been shown to be double than those of cells grown on 
glucose (Chen et al., 2008). This suggests that the various mitochondrial defects 
observed in taz1Δ mutant cells exacerbate their ethanol sensitivity.   
 In my work, I identified the branched-chain amino acid (BCAA) 
transaminase (BCAT) Bat1 and Bat2, mitochondrial and cytosolic proteins, 
respectively, as suppressors of the growth defects of yeast cells lacking TAZ1 
Along this line, supplying taz1Δ cells with the BCAA valine or aspartate, which is 
a product of a transamination reaction as well, improved their growth on ethanol 
without affecting their lipid composition. This observation is surprising since 
although both BCATs were reported previously to affect directly or indirectly 
several cellular processes, none has been linked to the pathogenesis of BTHS 
so far. Additionally, Bat1, but not Bat2, was identified as a high-copy suppressor 
of a temperature-sensitive mutation in ATM1, encoding a mitochondrial ABC 
transporter (Kispal et al., 1996).     
 Surprisingly, overexpression of BAT1 or BAT2 did not reverse the 
respiratory chain complexes assembly defects, the reduced membrane potential 
of mitochondria, or altered mitochondrial lipid profiles, i.e. the decreased CL and 
increased MLCL levels. Hence, I can hypothesize that the rescued taz1 mutant 
growth defects exerted by BCATs is not related to the primary mitochondrial 
defects of losing Taz1 function, but rather to secondary defects characteristic of 
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these cells. In fact, both BCATs yeast homologs have been implicated to be 
critical for the activation of TORC1 signalling, a process that is in turn is 
coordinated by the TCA cycle flux (Kingsbury et al., 2015). Indeed, liquid 
chromatography coupled with mass spectrometry (LC-MS) analysis performed by 
my collaboration partners verified that the TCA metabolites and some amino 
acids levels are decreased in taz1Δ cells and their levels are restored upon 
overexpression of Bat1/2. In fact, BAT1 overexpression in taz1Δ cells restored 
the decreased levels of most of the TCA cycle metabolites and of the beneficial 
amino acids valine and histidine.      
 Remarkably, the growth defect rescue only occurred upon 
supplementation with one out of three of the BCAAs. This data is consistent with 
a recent study in which it has been reported that the levels of both remaining 
BCAAs, leucine or isoleucine, were not affected by disruption of BAT1 or BAT2 
(Takpho et al., 2018). This observation suggests that the mitochondrial 
biosynthesis of valine is more prominent than its cytosolic synthesis, and can also 
explain why the growth rescue by BAT1 overexpression was better than with its 
cytosolic homologue.       
 Although I assessed the protein expression of each BCAT individually, due 
to their high sequence homology, which hinders their individual detection, I 
cannot exclude that these isoforms are differently expressed.   
 Finally, to corroborate in a mammalian model the findings obtained with a 
yeast model of BTHS, my collaboration partners tested the effects of human 
BCATs homologs and supplementation with valine on the proliferation of TAZ-/-  
cells. They could show that the mitochondrial BAT homolog, but not the cytosolic 
one, enhanced significantly the proliferation of MEF cells lacking TAZ. 
Additionally, valine supplementation resulted in an increased proliferation of TAZ 
mutant mammalian cells. Hence, the observed growth defect rescue with the two 
different BCAT isoforms and with valine supplementation is consistent in both 
yeast and mammalian cells.      
 Previous studies reported beneficial effects of amino acids in several 
analogous contexts. For example, dietary supplementation of BCAAs has been 
shown to revert structural and functional mitochondrial damages in rodents with 
alcoholic liver disease (Tedesco et al., 2018). Furthermore, a link between 
impaired CL remodeling and amino acids metabolism is further supported in a 
Discussion 
 
40 
 
TAZ knock-down mouse model in which the increased MLCL/CL ratio led to a 
substrate shift via de novo amino acid biosynthesis as well as amino acid usage 
by the TCA cycle (Kiebish et al., 2013).     
 Currently, the pathomechanism of BTHS is not clear and although the 
molecular pathway behind these observations remains obscure, these findings 
could clearly open up a new and previously unknown direction to learn more 
about the mechanism of BTHS. One possibility is that BCATs provide substrates 
to the TCA cycle, and aspartate can be deaminated to produce oxaloacetate, 
therefore also feeding the cycle. However, since it is hard to determine how much 
of the externally added metabolites are actually transported across the cell wall, 
plasma membrane and into the mitochondrial matrix, we cannot exclude that 
differences in rescue ability reflect variations in the effective transport of the 
different molecules, Alternatively, supplementation of certain amino acids can 
enhance cellular growth indirectly by their induction of the mTOR signalling 
pathway.        
Collectively, these results also hint to a potential use of branched-chain 
amino acids as a therapeutic avenue to treat patients with Barth syndrome. 
 
8.3. ER-Mitochondria Encounter Structure (ERMES) coordinates coenzyme 
Q biosynthesis 
 
The absence of vesicular lipid exchange among mitochondria and other 
cellular compartments proposes that the exchange of lipids between the ER, 
where most PLs biosynthesis takes place, and mitochondria must occur via inter-
organelle close contacts (Dimmer and Rapaport, 2017; Kornmann et al., 2009). 
While the subunits and respective localization of the ER-mitochondria encounter 
structure (ERMES) complex, and its function as a multi-protein tether that 
mediates PL transfer is well defined, additional roles of ERMES are less explored 
(Lahiri et al., 2014b). It is still puzzling why the loss of a functional ERMES 
complex leads to so many unrelated phenotypes in yeast cells. Although the 
ERMES complex is not conserved in higher eukaryotes, several proteins have 
been described as potential tethers between ER and mitochondria in metazoans. 
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Interestingly, in similarity to the situation in yeast, such tether proteins in higher 
eukaryotes are also involved in different physiological processes. for a prominent 
example is the mitochondrial protein mitofusin Mfn2, which is involved in ER-
mitochondria contacts, and whose deletion displays decreased CoQ levels, 
ultimately leading to defective respiration (de Brito and Scorrano, 2008; Mourier 
et al., 2015). Additionally, the ATPase Coq8A that is involved in both the 
assembly of the high molecular mass multisubunit complex (CoQ synthome) and 
in de novo biosynthesis of CoQ, belongs to the family of ADCKs. Interestingly, 
the human homologues of the Mdm10 complementing protein, Mcp2 belong also 
to this family (Reidenbach et al., 2018). These findings are in line with our 
observation that loss of functional ERMES complex leads to destabilization of the 
yeast CoQ synthome.        
 Our data show that ERMES seem to be located above specialized matrix 
niches where the CoQ synthome is enriched, suggesting a spatially regulated 
process. Naturally, we cannot exclude the possibility that this observation might 
be an indirect consequence of the modified PL metabolism or altered 
mitochondrial function in ERMES mutants (Sinzel et al., 2016; Tan et al., 2013). 
 To date, there is no evidence for a direct interaction between ERMES and 
CoQ synthome subunits. Nevertheless, work done by our collaboration partners 
demonstrated that Coq10 is involved in the apparent coordination of the CoQ 
synthome by the ERMES complex, suggesting a direct role yet unclear 
mechanism by which this tether mediates CoQ biosynthesis (Eisenberg-Bord et 
al., 2018). Although Coq10 is not part of the CoQ synthome, it has been reported 
to chaperone CoQ6 and late-stage CoQ6-intermediates from the location where 
they are synthesized to the sites where they exerts their function (Allan et al., 
2013; Barros et al., 2005). Furthermore, in the yeast genome both COQ10 and 
MDM12 genes are adjacent, suggesting that they might share a promoter (Cherry 
et al., 2012). Indeed, yeast gene expression microarray analysis have 
demonstrated that the both genes are co-expressed (Hibbs et al., 2007Hibbs et 
al., 2007). Hence, it is tempting to speculate that the transcriptional co-regulation 
between COQ10 and MDM12 might be the basis for the coordination of the levels 
of Coq10 polypeptide and the ERMES complex to assist a better positioning of 
the CoQ synthome at the proximity of the ER-mitochondria contact site. 
 In fact, it was demonstrated that in the absence of a functional ERMES 
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complex the mRNA levels of the COQ genes and the cellular levels of CoQ6 were 
increased. Surprisingly, the steady state levels of the proteins encoded by the 
aforementioned mRNAs were unaltered in the mutant cells and the mitochondrial 
levels of CoQ6 were reduced (Eisenberg-Bord et al., 2018). These findings 
suggest a scenario where mitochondria have a defective leakage of CoQ6, which 
is followed by a compensatory signalling to the nucleus to upregulate transcription 
of CoQ genes. Such communication between mitochondria and nucleus to cope 
with cellular alterations has been previously described (Eisenberg-Bord and 
Schuldiner, 2017).    
In conclusion, our study revealed that ERMES complex and coenzyme Q 
biosynthesis are intimately connected, however the mechanism by which this 
occurs is still unknown. Future detailed studies on the interplay between CoQ6 
biosynthesis and the ER-mitochondria contact site will allow identifying possible 
alternative factors that have evolved to serve similar functions in eukaryotes.  
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Introduction
In eukaryotic cells, exchange of membrane lipids between or-
ganelles is critical for sustaining their biogenesis and function. 
How lipids are exchanged with organelles that are not part of 
the vesicular transport network, such as mitochondria, remains 
unclear. Recent research stresses the importance of membrane 
contact sites (MCSs), zones of close proximity (10–30 nm) be-
tween two organellar membranes, as a means of nonvesicular 
lipid exchange between organelles (Helle et al., 2013; Phillips 
and Voeltz, 2016). In yeast and other fungi, an MCS between 
the ER and mitochondria is constituted by the ER–mitochon-
dria encounter structure (ERM ES). This protein complex con-
sists of an ER transmembrane protein, Mmm1; a mitochondrial 
outer membrane protein, Mdm10; and two peripheral mem-
brane proteins, Mdm12 and Mdm34 (Kornmann et al., 2009; 
Ellenrieder et al., 2016). ERM ES tethers the ER to mitochon-
dria, and three of its four core components bind lipid molecules 
through a tubular lipid–binding domain. Tubular lipid domains 
can extract lipid molecules from a membrane, shelter them from 
the cytosol, and deliver them to another membrane, thus acting 
as membrane lipid transporters (Kopec et al., 2010; Schauder et 
al., 2014; AhYoung et al., 2015; Jeong et al., 2016).
Despite this seemingly crucial role in mitochondrial 
membrane biogenesis, ERM ES deficiency is not lethal and does 
not completely block lipid delivery to mitochondria (Kornmann 
et al., 2009). This is likely due to the existence of redundant 
pathways. One such pathway involves the formation of an MCS 
between the mitochondria and the vacuole. This MCS can be 
readily evidenced by the overexpression of the vacuolar fusion 
factor Vps39, which leads to the formation of extensive vacuole 
and mitochondria patches (vCLA MPs; Elbaz-Alon et al., 2014; 
Hönscher et al., 2014). The tethering of these two organelles 
is mediated by Vps39, the vacuolar Rab GTPase Ypt7, and a 
hypothetical mitochondrial factor. Simultaneous inactivation of 
ERM ES and Vps39 is lethal and strongly reduces mitochondrial 
lipid import (Elbaz-Alon et al., 2014).
Therefore, a likely role for the ER–mitochondria MCSs is 
to deliver lipids to mitochondria from the ER, a function that is 
shared by vacuole–mitochondria MCSs. However, the compen-
sation by redundant pathways is only partial because mutations 
that impair ERM ES lead to a host of mitochondrial phenotypes. 
This suggests that redundant pathways are able to provide lipids 
to the mitochondria but are probably insufficient to completely 
compensate for the loss of ERM ES.
Interestingly, the phenotypes associated with ERM ES 
deficiency can be reverted by the overexpression of two mito-
chondrial proteins, Mcp1 and Mcp2, or by single amino acid 
substitutions in Vps13 (Tan et al., 2013; Lang et al., 2015; Park et 
al., 2016). Both Mcp1 and Mcp2 are integral membrane proteins 
that reside on the outer and inner mitochondrial membrane, re-
spectively, and their molecular functions remain unclear. Vps13 
is a conserved ∼360-kD protein that localizes to endosomes, 
to vacuole–mitochondria and mitochondria–endosome contact 
sites, and, upon glucose starvation, to the nuclear–vacuole junc-
tions (Lang et al., 2015; Park et al., 2016). MCP1, MCP2, and 
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VPS13 are all synthetically lethal with the loss of ERM ES, indi-
cating that they function in ERM ES-redundant pathways.
Together, this suggests that ERM ES-redundant pathways 
can be boosted to render ERM ES entirely dispensable. Yet 
whether Mcp1, Mcp2, and Vps13 function at mitochondria–
vacuole contacts is unclear. The fact that VPS13 suppressor al-
lele can exert its suppressive functions only in the presence of 
Vps39 and Mcp1, but independent of Mcp2 (Lang et al., 2015), 
suggests that Vps13, Mcp1, and Vps39 might constitute one co-
herent unit to mediate the tethering and function of vacuole–mi-
tochondria MCSs and ensure cell survival in the absence of the 
ERM ES complex. Here we investigate the relationship among 
Mcp1, Vps13, and Vps39. We show that Mcp1 recruits Vps13 
to mitochondria and vCLA MPs and that this recruitment under-
lies the functionality of vacuole–mitochondria contacts in the 
ERM ES bypass pathway. Our data support a model in which 
Vps39 and its binding partners establish tethering between mi-
tochondria and vacuole, whereas Mcp1 and Vps13 participate 
in the functional output of mitochondria–vacuole contact sites 
to restore cellular growth and homeostasis.
Results
To address in an unbiased manner how Vps13 is involved in 
bypassing ERM ES function, we inspected two published ge-
netic interaction datasets (Costanzo et al., 2010; Hoppins et al., 
2011). Synthetic genetic screens involve the creation of dou-
ble-deletion strains, monitoring their growth, and computing 
genetic interaction scores. A highly powerful way to analyze 
genetic interaction data is to compute correlations between 
profiles of genetic interactions (Collins et al., 2010) in which 
strong positive correlations are typically indicative of a com-
mon function. According to Costanzo et al. (2010), the gene that 
best correlated with VPS13 was VPS38, and the second best was 
VPS30 (Fig. 1 A). In the dataset of Hoppins et al. (2011), which 
did not contain VPS38, the best-correlated gene was VPS30 
(Fig. 1 A). Both Vps30 and Vps38 are part of the phosphati-
dylinositol-3 kinase (PI3K) complex II, together with Vps34 
(Kihara et al., 2001), which was absent from both datasets. 
The PI3K complex II is important for vacuolar protein sorting 
and is targeted to endosomes and vacuole by Vps38 (Obara et 
al., 2006). The link between Vps38/Vps30 and Vps13 in pro-
tein sorting along the endocytic pathway is further supported 
by a recent study showing that Vps13 is necessary for trans-
port between trans-Golgi and late endosomes (De et al., 2017). 
Moreover, a hidden Markov model–based homology prediction 
uncovered a putative Pleckstrin homology (PH)–like domain at 
the extreme C terminus of Vps13 (Fig. 1 B and Alignments S1–
S3; Söding et al., 2005; Fidler et al., 2016). The strong correla-
tion with PI3K complex II subunits along with the presence of 
a PH-like domain at the C terminus of Vps13 suggests a nexus 
between Vps13 and the endocytic pathway via phosphatidyli-
nositol-3-phosphate. Indeed, Vps13 localizes to Vps38-positive 
early endosomes (Huh et al., 2003; Fig. 2 A).
We hypothesized that Vps38 may recruit Vps13 to the en-
dosomes either by itself or via phosphatidylinositol-3-phosphate. 
To directly test this idea, we deleted vps38 in a strain express-
ing a functional GFP-tagged Vps13 (Vps13^GFP; Lang et al., 
2015). To our surprise, Vps13 remained on FM4-64-positive, 
defective endosomes found in vps38Δ cells (Fig. 1 C; Luo and 
Chang, 1997). This observation suggested that Vps13 requires 
Figure 1. The function of Vps13 on endosomes is unlinked to its function 
in ERM ES suppression. (A) Correlation analysis of the genetic interactions 
of VPS13. Correlation coefficients were calculated for the genetic interac-
tion profile of VPS13 and all genes present in the Costanzo et al. (2010) 
dataset (left) and Hoppins et al. (2011) dataset (right). (B) Domain archi-
tecture of yeast Vps13. Repeat-containing domains are mapped according 
to Velayos-Baeza et al. (2004). Predictions were made using a hidden 
Markov model–based homology search (HHPred; Söding et al., 2005). A 
PH-like domain was detected at the C terminus (3,037–3,133 aa) when 
searched against the Protein Data Bank. (C) Vps13 remains on endosomes 
in vps38Δ cells. Localization of GFP-tagged endogenous Vps13 in WT 
and vps38Δ cells. Vacuoles and endosomes are stained with FM4-64. 
Bar, 2 µm. (D) Genetic interaction profile of VPS13 (x axis) plotted against 
VPS38 and VPS30 (y axis; left and middle) using data from Costanzo et 
al. (2010). (Right) The profile of VPS13 versus VPS30 using data from 
Hoppins et al. (2011). The correlation in the genetic interaction profiles 
of VPS13 with that of both VPS30 and VPS38 is highlighted by the green 
area. Genes encoding ERM ES members as well as PSD1 and HAP3 are 
circled in red when present.
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Figure 2. Relationship between Vps13 and suppressors of ERM ES defects. (A, top) Localization of internally GFP-tagged Vps13 (WT or suppressor; Vps13 
bearing the internal GFP tag that retains its functionality is depicted as Vps13^GFP) with mCherry-tagged Vps38 expressed from endogenous promoters. 
Mitochondria are marked by a plasmid-encoded, matrix-targeted BFP (mtBFP). White and pink arrowheads mark Vps13 foci that do or do not colocal-
ize with Vps38, respectively. (Bottom) Localization of GFP-tagged Vps13 (WT or suppressor) with mCherry-tagged Pex10 expressed from endogenous 
promoters. Pink arrowheads point at Vps13 foci that colocalize with peroxisomes marked by Pex10-mCherry. Bar, 2 µm. (B) Localization of endogenous 
Vps13 under normal conditions or upon overexpression of Vps39 or Mcp1 (VPS39↑ and MCP1↑, respectively). Vacuoles are stained with FM4-64. 
Bars, 2 µm. Arrowheads indicate vacuole–mitochondria patches (vCLA MPs). The Vps13 suppressor version is expressed from a low-copy plasmid, under 
the control of its native promoter. (C) Mcp1-mediated growth rescue requires both Vps13 and Vps39. The ts strain mmm1-1 with the indicated genotypes 
was spotted as serial dilutions on yeast extract peptone dextrose plates and grown either at RT or 37°C. (D, top) Maximum intensity projection of five 
Z-sections showing the localization of endogenous GFP-tagged Vps39 (green) in WT and Mcp1-overexpressing cells. Mitochondria are marked by mtBFP 
(shown in red). (Bottom) WT or vps13Δ cells expressing GFP-tagged Vps39, from the strong GPD promoter, were stained with DAPI to visualize mitochon-
drial DNA (shown in red). Bars, 2 µm. (E) Vps39 overexpression does not rescue temperature-induced dysfunction of ERM ES subunit Mmm1. Strains with the 
indicated genotype were spotted as in C. (F) Tetrad dissection of sporulated MDM10/mdm10Δ VPS39/GPDpr-GFP-VPS39 diploids. Genotype of individual 
spores is indicated with color-coded circles.
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neither Vps38 nor phosphatidylinositol-3-phosphate, made by 
PI3K complex II, to localize to endosomes. Furthermore, the 
analyses of genetic interaction datasets also showed that de-
spite the strong similarity in the genetic interaction profiles of 
VPS13, VPS38, and VPS30, several genes had synthetic genetic 
interactions with VPS13 only (Fig. 1 D). These genes encode 
members of the ERM ES complex (MDM10 and MDM12) and 
other factors associated with mitochondrial function, includ-
ing PSD1, encoding phosphatidylserine decarboxylase, which 
makes phosphatidylethanolamine from phosphatidylserine at 
the inner mitochondrial membrane, and HAP3, a transcriptional 
regulator of respiratory gene expression (Mattoon et al., 1990). 
Collectively, we conclude that Vps13 functions in the endocytic 
pathway in a way that correlates with PI3K complex II but that 
this function is probably separable from its role in substituting 
the functions of the ERM ES complex.
Because Vps13 function in the ERM ES bypass pathway 
appeared disconnected to its role at the endosome, we rea-
soned that the ability of Vps13 to suppress ERM ES function 
might be linked to an alternative subcellular localization. We 
colocalized Vps13 with different organellar markers in various 
ERM ES-suppressing conditions. We assessed Vps13 local-
ization when it bore a suppressing mutation (L1627S), when 
vacuole–mitochondria MCSs were exacerbated into vCLA MPs 
by Vps39 overexpression, and upon Mcp1 overexpression. As 
expected, in normal conditions, a majority (60 ± 1.7%, mean ± 
SEM) of the Vps13 foci colocalized with the endosomal marker 
Vps38 (Fig. 2 A, top). In contrast, a much smaller fraction (17.5 
± 0.8%) of Vps13 bearing the suppressor mutation localized 
to Vps38-positive foci. To address the localization of remain-
ing foci, we performed colocalization with different organellar 
markers (not depicted) and found that these foci mostly corre-
sponded to peroxisomes (Fig. 2 A, bottom). Indeed, in contrast 
to 6.8 ± 1.6% of WT Vps13 foci, 41.1 ± 1.23% of the Vps13 
suppressor foci localized to Pex10-positive peroxisomes. We 
also observed that Pex10-positive peroxisomes only seldom 
(0.43 ± 0.28%) colocalized with Vps38-positive endosomes 
(Fig. S1). Upon Vps39 overexpression, there was no change in 
the localization of Vps13 (Fig. 2 B, VPS39↑), even though large 
vCLA MPs, indicative of vCLA MP formation, could be seen 
(arrowheads). Intriguingly, when Mcp1 was overexpressed, 
Vps13 relocalized to mitochondria. The relocalization was also 
observed for the suppressor allele, but in a more dotted fashion 
(Fig.  2 B, MCP1↑). Thus, whereas a suppressor mutation in-
duces the relocalization of Vps13 to peroxisomes, Mcp1 over-
expression induces the relocalization of both the Vps13 WT and 
suppressor mutant to mitochondria. Of note, vCLA MP induc-
tion has largely no effect on Vps13 localization.
As the ability of Mcp1 to suppress ERM ES defects was 
in line with the dramatic localization phenotype of Vps13, we 
tested whether Mcp1 overexpression required VPS13 to bypass 
ERM ES function. To this end, we used the mmm1-1 tempera-
ture-sensitive (ts) strain, which manifests the typical slow-growth 
phenotype of ERM ES mutants at the restrictive temperature 
only. Overexpression of Mcp1 in this strain rescued the growth 
phenotype at 37°C, in accordance with published data (Tan et 
al., 2013). However, deletion of vps13 completely abolished the 
ability of MCP1 overexpression to rescue the loss of MMM1 
function (Fig. 2 C), suggesting that Vps13 recruitment to mito-
chondria is a critical event in the ERM ES bypass pathway.
We also found that Vps38 was necessary neither for the 
Vps13- nor for the Mcp1-mediated rescue (Fig. 2 C and Fig. S2), 
confirming our earlier conclusion that Vps38 is not linked to the 
function of Vps13 in rescuing the loss of ERM ES. (Fig. 1 D).
Our colocalization analysis also suggested that peroxi-
somes could be involved in the bypass pathway (Fig. 2 A). To 
test this genetically, we deleted pex1 in the mmm1-1 ts strain 
overexpressing Mcp1. Cells lacking PEX1, a critical factor for 
peroxisomal biogenesis, lack functional peroxisomes and har-
bor only peroxisomal “ghosts” that do not have any matrix pro-
teins (Knoops et al., 2015). Interestingly, Mcp1 overexpression 
rescued loss of MMM1 function even in the absence of pex1 
(Fig. 2 C), indicating that functional peroxisomes are not neces-
sary to bypass ERM ES functions. Therefore, it is possible that 
the localization of the suppressor mutant to peroxisomes is an 
epiphenomenon unrelated to ERM ES suppression.
Finally, we found that Vps39 was necessary for Mcp1 to 
rescue the mmm1-1 growth defect (Fig.  2  C). This is consis-
tent with the fact that Vps39 is also necessary for suppressor 
alleles of Vps13 to exert their suppressive function (Lang et al., 
2015). However, Mcp1 overexpression, like the expression of 
Vps13 suppressor alleles (Lang et al., 2015), did not lead to vis-
ible Vps39-mediated vCLA MP formation (Fig. 2 D, top), and 
vCLA MP formation upon Vps39 overexpression was not depen-
dent on the presence of Vps13 (Fig. 2 D, bottom). We then won-
dered if Vps39 overexpression-mediated vCLA MP formation 
was sufficient to rescue the loss of ERM ES function. Because 
of the rapidity of suppressor accumulation in haploid strains 
bearing ERM ES mutations, we used either a mmm1-1 ts mutant 
or tetrad-dissected heterozygous diploid strains. Surprisingly, 
we found that vCLA MP formation mediated by Vps39 over-
expression rescued neither the growth defect of a ts mmm1-1 
strain (Fig. 2 E) nor, contrary to published literature (Hönscher 
et al., 2014), of an mdm10Δ strain (Fig.  2  F). Actually, WT, 
mdm10Δ, and mmm1-1 cells, overexpressing VPS39 from the 
strong GPD promoter, grew slower than cells expressing VPS39 
from its endogenous promoter. Collectively, these results indi-
cate that vCLA MPs induced by Vps39 overexpression are not 
sufficient by themselves to compensate for the loss of ERM ES.
Because overexpression of Mcp1 clearly shifted most of 
the Vps13 signal to mitochondria, we wondered if Mcp1 might 
be a limiting binding partner for Vps13 on mitochondria. To 
address this, we coimmunoprecipitated HA-tagged Mcp1 to-
gether with either the WT or suppressor (L1627S) GFP-tagged 
Vps13, expressed from their endogenous promoters. We found 
that both the WT and suppressor versions interacted with Mcp1 
(Fig.  3  A). Mcp1 is a membrane protein with five predicted 
transmembrane domains. Only short regions that stick out of 
the membrane could potentially interact with Vps13 (Fig. 3 C). 
To assess which part of Mcp1 interacted with Vps13, we first 
assessed Mcp1 topology by exposing purified mitochondria 
overexpressing C-terminally HA-tagged Mcp1 to increasing 
amounts of proteinase K (PK). We then detected protected frag-
ments by Western blotting, using either an anti-HA antibody to 
detect the C terminus or an antibody raised against the N termi-
nus of Mcp1 (aa 20–40). At small amounts of PK, both antibod-
ies detected the appearance of fragments of 20 kD (Fig. 3 B), 
indicating cleavage at the level of loop 2 and an N-out, C-in 
conformation for Mcp1 (Fig.  3  C). Interestingly, the N- 
terminal fragment remained protease resistant even at large PK 
concentrations, suggesting either that the epitope was too close 
to the membrane to be accessible to PK or that this domain is 
tightly folded. An N-out, C-in conformation indicated that two 
domains could potentially interact with Vps13, namely, the 
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N terminus (aa 1–61) and loop 2 (aa 122–173), whereas loop 
4 appeared too short to serve as a binding site. To assess if any 
of these fragments was binding to Vps13, we adopted a relocal-
ization approach in which we targeted these two segments of 
Mcp1 to the ER (Fig. 3 D) and asked if Vps13 follows any of 
these segments. Strikingly, expressing the N terminus fused to 
an ER-targeted red fluorescent protein (mCherry–Ubc6) led to 
the recruitment of Vps13 to the ER. The same effect was not ob-
served for the fusion protein containing loop 2 (Fig. 3 D). Thus, 
the N-terminal fragment (1–61 aa) of Mcp1 was sufficient for 
the binding of Vps13 and its recruitment to a foreign organelle.
Suppressor mutations identified in Vps13 all cluster to the 
repeat-containing domains (Lang et al., 2015; Park et al., 2016). 
We wondered if these domains or any other region was involved 
in Mcp1-mediated recruitment. To this aim, we performed a se-
ries of N- and C-terminal truncations on the endogenous Vps13 
and asked if the truncated versions were still able to localize to 
mitochondria upon Mcp1 overexpression. Vps13 C-terminally 
truncated up to aa 2,599 was robustly recruited to mitochon-
dria. Shorter truncations remained, however, mostly cytoplas-
mic (Fig. 3, E and F). Short N-terminal truncations destabilized 
the protein, such that their localization was difficult to assess. 
However, a larger deletion up to aa 2,247 was recruited to the 
mitochondria. Even though, in this case, the fluorescence lev-
els were low, the mitochondrial localization was evident only 
in  MCP1 overexpression conditions (Fig. 3 E, bottom). Thus, 
the Mcp1-binding region (aa 2,247–2,599) of Vps13 does not 
overlap with the region harboring suppressor mutations, in 
agreement with the fact that the suppressor mutation does not 
act by increasing Vps13/Mcp1 interaction (Fig. 3 A). Dominant 
suppressor mutations therefore probably act by relieving an in-
hibitory activity in Vps13 (Lang et al., 2015), without affecting 
its mitochondrial recruitment.
Having established the key elements of Mcp1-Vps13 in-
teraction, we asked if the only function of Mcp1 in the ERM 
ES-bypass pathway is to recruit Vps13 to mitochondria. To 
test this, we constructed a minimal mitochondrial recruiting 
fragment by fusing aa 1–61 of Mcp1 to an outer mitochondrial 
membrane-targeted red fluorescent protein (mCherry–Fis1) and 
asked whether its expression could suppress the phenotype of 
the mmm1-1 ts strain at the restrictive temperature. The expres-
sion of this construct, but not of mCherry–Fis1 alone, led to the 
strong recruitment of Vps13 to mitochondria (Fig. 4 A). How-
ever, the growth phenotype was not rescued at 37°C upon the loss 
of functional Mmm1 (Fig. 4 B). This was not due to a failure of 
Mcp1 (1–61 aa) to recruit Vps13 onto mitochondria in ERM ES 
mutant conditions, as Vps13 was recruited to mitochondria even 
at the restrictive temperature (Fig. 4 A, right). In fact, mmm1-1 
ts strain expressing the Mcp1 (1–61 aa) construct grew worse 
than the nonexpressing parent, indicating that the nonfunctional 
fragment likely titrated Vps13 away from the functional, full-
length Mcp1 (Fig. 4 B). We conclude that Vps13 recruitment 
to mitochondria is necessary but not sufficient to rescue the 
loss of ERM ES function. Thus, full-length Mcp1, in addition 
to recruiting Vps13, plays an active role in the ERM ES bypass 
pathway. Indeed, a hidden Markov model homology analysis 
(HHPred) suggested that Mcp1 might fold as a five-helix bun-
dle, as in succinate dehydrogenase and quinol–fumarate re-
ductases (Alignment S4), pointing to a role beyond the mere 
recruitment of Vps13. We used homology modeling to construct 
a model of MCP1. The homology started at aa 45 of Mcp1, 
that is, close to the first transmembrane region, and extended 
until the end of the protein. In the model, four histidines (H72, 
H114, H187, and H237) constituted two putative heme-binding 
domains (Fig. 4 C), as in the quinol fumarate reductase from 
Wolinella succinogenes, which served as a template for homol-
ogy modeling. Mcp1 is conserved within a subgroup of asco-
mycetes. Therefore, to address if heme binding is a conserved 
feature of Mcp1, we aligned MCP1 in several fungi. Although 
the homology was generally good within transmembrane do-
mains, the presumptive heme-binding histidines were among 
the completely conserved amino acids, suggesting that heme 
binding is an important feature of Mcp1 (Fig. 4 D). Indeed, mu-
tating histidine residues in either presumptive heme-binding do-
mains (H187A and H237A, respectively) severely blunted the 
ability of Mcp1 to rescue ERM ES defects when overexpressed 
(Fig.  4  E), without affecting Vps13 recruitment to mitochon-
dria (Fig. 4 F). Mutating other conserved residues (P195A and 
G241A) yielded variable outcomes on ERM ES rescue but did 
not affect Vps13 recruitment, as expected.
In summary, Vps13 and Mcp1 interact either directly or in-
directly on the mitochondrial surface. This interaction is neces-
sary for the ERM ES bypass pathway, but merely bringing Vps13 
to mitochondria is not sufficient, and presumptive heme-bind-
ing domains are important for the ERM ES-rescue phenomenon.
How does this bypass work? It is logical that an MCS 
can be bypassed by another MCS, and in this case, vacuole–
mitochondria contacts might serve as an alternative MCS. In-
deed, both Vps13- and Mcp1-mediated suppression require 
Vps39 (Lang et al., 2015; Fig.  2  C). However, two observa-
tions challenge the idea that vacuole–mitochondria contacts are 
involved in ERM ES suppression. First, vCLA MP formation 
through Vps39 overexpression does not alter Vps13 localiza-
tion (Fig. 2 B). Conversely, neither the Vps13 suppressor alleles 
nor Mcp1 overexpression induces the formation of vCLA MPs 
(Lang et al., 2015; Fig. 2 D).
In an effort to resolve this paradox, we co-overex-
pressed Vps39 and Mcp1 in cells expressing Vps13^GFP. In 
this case, Vps13 was not only recruited to mitochondria by 
Mcp1 but was robustly enriched at Vps39 overexpression- 
mediated vCLA MPs (Fig. 5 A).
Discussion
Here we show that Mcp1 and Vps13 interact at vacuole– 
mitochondria interfaces and require Vps39 function in the 
ERM ES-bypass pathway. What is the relationship among these 
three factors? Unlike the overexpression of Mcp1 or the ex-
pression of the Vps13 suppressor, the overexpression of Vps39, 
despite causing the formation of vCLA MPs, is incapable of 
reverting ERM ES growth phenotype (Fig. 2, E and F), in con-
trast to previously reported findings (Hönscher et al., 2014). In 
contrast, Mcp1- and Vps13-mediated ERM ES rescue happens 
in conditions in which vacuole–mitochondria contacts are not 
enlarged into vCLA MPs. These results indicate that the amount 
and activity of Vps13 targeted to mitochondria, but not the en-
hanced surface of contact between the organelles, are limiting 
for the output of the bypass pathway.
Vps13 is enriched at vCLA MPs only when both Vps39 
and Mcp1 are co-overexpressed. This suggests that when Vps39 
overexpression mediates vCLA MP formation, Vps13 fails 
to accumulate there, because Mcp1 is limiting for its recruit-
ment to mitochondria. Conversely, when Mcp1 overexpression 
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Figure 3. Mcp1 recruits Vps13 to mitochondria. (A) Cells expressing Vps13^GFP (WT or suppressor) along with HA-tagged Mcp1 were subjected to 
immunoprecipitation (IP) using GFP–TrapA beads. Eluates from the beads were analyzed by SDS-PAGE and Western blotting using antibodies against 
GFP, HA, or yeast porin, Por1 (negative control). Note that the GFP antibody did not detect endogenous Vps13 in whole-cell lysates (asterisks). (B) PK 
accessibility assay. Isolated mitochondria were incubated in presence of the indicated amounts of PK and then subjected to Western blotting with the 
indicated antibodies. Proteolytic fragments I, II, and III are indicated. Asterisk denotes uncharacterized PK-independent fragment. (C) Topology of Mcp1 
and proteolytic fragments on the outer mitochondrial membrane (OMM). Mcp1 bears five transmembrane (TM) helices (TM1–TM5) and four loops (L1–L4). 
The cytosol-exposed N terminus (aa 1–61) and L2 (aa 122–173) are shown in blue and brown, respectively. IMS, intermembrane space. (D) Localization 
of endogenous Vps13 (green) with ER-targeted mCherry alone or fused to the indicated Mcp1 fragments, expressed from a plasmid. (E) Mapping the 
Mcp1-binding region of Vps13. (Top) Localization of full-length Vps13 and the indicated truncations C-terminally tagged with GFP, upon Mcp1 overex-
pression. (Bottom) Localization of full-length Vps13 and the indicated truncated version N-terminally tagged with GFP, under normal conditions and Mcp1 
overexpression. The expression of the N-terminal truncations was driven by the CYC1 promoter. All truncations were performed genomically. (F) Schematic 
representation of C-terminal and N-terminal truncations and their mitochondrial recruitment upon Mcp1 overexpression. The region of interaction with 
Mcp1 lies between aa 2,247 and 2,599. n.d., not determined. Bars, 2 µm.
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Figure 4. Mcp1 has additional functions besides recruiting Vps13. (A) Cells coexpressing Vps13^GFP and either mitochondria-targeted mCherry alone or 
mCherry fused to the Mcp1 fragment 1–61 were grown at RT (left). To inactivate Mmm1, cells were shifted to 37°C for 2 h and imaged (right). Note the 
altered mitochondrial morphology at the restrictive temperature. OMM, outer mitochondrial membrane. (B) The mmm1-1 ts strains carrying an empty vector 
or the vector bearing the Mcp1 fragment 1–61 were spotted as serial dilutions on SD-HIS plates and grown for 2 d either at RT or 37°C. The mmm1-1 ts 
strain with Mcp1 overexpression along with empty vector served as a positive control for growth rescue at the restrictive temperature. (C, top) The structure 
of the membrane-spanning component of the fumarate quinol reductase from W. succinogenes (left; Protein Data Bank 2BS2) was used for homology model-
ing of Mcp1. (Right) Magnification of the heme-binding sites in the fumarate quinol reductase and their predicted location in Mcp1. (D) Alignment of Mcp1 
α-helices 1, 3, 6, and 7 in different ascomycetes orthologues. (E) mmm1-1 ts mcp1Δ cells transformed with plasmids overexpressing WT or mutant Mcp1 
were spotted as serial dilutions and grown at either RT or 37°C. (F) Live cells expressing Vps13^GFP and overexpressing indicated mutants of Mcp1 were 
counterstained with DAPI to reveal mitochondria and nuclei (dashed lines). Bars, 2 μm.
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recruits Vps13 to mitochondria, Vps13 is not visibly enriched at 
vacuole–mitochondria contacts, because the surface of contact 
between both organelles is limiting.
A model that reconciles our observations is that Vps39 
acts as a vacuole–mitochondria tether, while Vps13 and Mcp1 
act as physiological effectors of vacuole–mitochondria MCSs 
function, which can compensate for the absence of ERM ES 
(Fig. 5 B). In this case, the tethering and physiological output 
of vacuole–mitochondria MCSs would be performed by sepa-
rate factors. Such a division of labor between tethers and effec-
tors at MCSs is novel, as most MCS proteins described so far 
harbor both tethering and physiological effector activities. For 
instance, ERM ES has an important tethering activity but also 
harbors lipid exchange proteins (Kornmann et al., 2009; Ah-
Young et al., 2015; Jeong et al., 2016). The same is true for ex-
tended synaptotagmins, which both tether the ER to the plasma 
membrane and transport lipids (Manford et al., 2012; Schauder 
et al., 2014; Saheki et al., 2016).
Consistent with biochemical tethering activity, Vps39 is 
a known member of the homotypic fusion and protein sorting 
complex, which is involved in the tethering of late endosomes 
and vacuoles (Bröcker et al., 2012). By contrast, Vps13 is 
known to function at MCSs that are tethered by other factors, 
for instance, nuclear–vacuole junctions tethered by Nvj1 and 
Vac8 (Pan et al., 2000).
Our elucidation of the mechanism of suppression by the 
Mcp1-Vps13-Vps39 module supports previous findings (Elbaz- 
Alon et al., 2014; Hönscher et al., 2014) and firmly establishes 
vacuole as a critical organelle involved in restoring mitochon-
drial homeostasis upon the loss of ER–mitochondria contacts. 
Although endosome–mitochondria (Park et al., 2016) and per-
oxisome–mitochondria contacts might play a role in ERM ES 
compensation, our data suggest that neither a fully functional 
endocytic pathway nor functional peroxisomes are required for 
this purpose (Fig. 2 C).
Because a core function of ERM ES appears to be lipid 
exchange and because Mcp1 and Vps13 serve as effectors of 
vacuole–mitochondria contacts, it is tempting to speculate that 
these two proteins are directly involved in lipid transport. Un-
like well-characterized lipid transport proteins that localize to 
organelle contact sites, Vps13 does not seem to harbor any 
known lipid transport domains based on sequence alignments. 
However, because only low-resolution structures of Vps13 are 
available (De et al., 2017), it cannot be excluded that Vps13 
harbors a yet uncharacterized lipid transport domain. In the 
case of Mcp1, our data point to an important role for the mem-
brane-embedded part of Mcp1. This segment likely folds as 
a heme-binding five-helix bundle, as in quinol–fumarate re-
ductases. This domain might be involved in lipid extraction 
from and/or lipid insertion into the outer mitochondrial mem-
brane. Whether heme binding serves oxidoreductive roles is 
unknown. Because Mcp1 is present only in a subset of asco-
mycetes, and because the five-helix bundle of Mcp1 resembles 
that found in the succinate dehydrogenases of gram-positive 
bacteria, it appears that Mcp1 is the result of a recent horizon-
tal gene transfer. It is thus possible that heme binding serves 
only a structural role in Mcp1. Consistent with this idea, over-
expressing a mutant protein presumably incapable of binding 
heme did severely blunt, but did not entirely abrogate, the ac-
tivity of Mcp1 in the ERM ES-bypass pathway (Fig. 4 E). Of 
note, succinate dehydrogenases and fumarate reductases use 
quinols and quinones as electron donors and acceptors and 
bind these lipids in dedicated cavities at the interface with the 
lipid bilayer. This lipid-binding ability might be exploited in 
the ERM ES bypass pathway to favor the desorption of phos-
pholipids from the membrane. Alternatively, it is conceivable 
that Mcp1 and Vps13 cooperate to recruit lipid transport pro-
teins that are yet to be identified.
Could the ERM ES bypass pathway be conserved in meta-
zoans? Like ERM ES subunits, Mcp1 is not conserved. How-
ever, Vps13 is highly conserved with four paralogs, Vps13A-D, 
in humans. Mutations in these genes are associated with dif-
ferent neurological disorders (Ueno et al., 2001; Kolehmainen 
et al., 2003; Tomiyasu et al., 2011). In particular, mutation in 
VPS13C, associated with a form of Parkinson’s disease, is linked 
to mitochondrial dysfunction (Lesage et al., 2016). Given that 
a short amino acid stretch alone is sufficient to recruit Vps13 
to mitochondria, it is conceivable that Mcp1 function has been 
Figure 5. Recruitment of Vps13 to vCLA MPs upon Vps39 and Mcp1 
co-overexpression. (A) Vps39 is genomically tagged with mCherry at its C 
terminus. Mitochondria are marked by a plasmid-encoded, matrix-targeted 
BFP (mtBFP). A single Z-section and a maximum intensity projection of five 
Z-sections are shown. White arrowheads point at vCLA MPs. Bar, 2 µm. 
(B) Proposed model for the mechanism of the ERM ES-bypass pathway. The 
recruitment of the vCLA MP factor Vps39 by the Rab GTPase Ypt7 anchors 
the vacuole to mitochondria via a yet unknown mitochondrial factor. This 
anchoring facilitates the recruitment of Vps13 to vacuole–mitochondria 
contacts sites by the outer mitochondrial membrane protein Mcp1. These 
two proteins potentially act in tandem to function as effectors of vacuole– 
mitochondria contacts.
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substituted by another mitochondrial protein in metazoans, 
despite low sequence conservation. Therefore, by shedding 
light on the mechanism of Vps13 recruitment and its function 
in vacuole/lysosome–mitochondria contact sites, our study has 
taken an important step toward understanding the function of 
the mitochondrial pool of Vps13 in health and disease.
Materials and methods
Yeast strains and plasmids
Strains used in this study are listed in Table S1. Genomic integration of 
PCR fragments was performed by homologous recombination (Puig et 
al., 1998; Janke et al., 2004; Gauss et al., 2005). Gene deletions were 
confirmed by colony PCR. Plasmids and primers used in the study 
are listed in Tables S2 and S3, respectively. mCherry was targeted 
to the ER by C-terminal fusion of aa 230–250 of Ubc6. Targeting to 
mitochondria was achieved by C-terminal fusion of aa 132–155 of 
Fis1. Plasmids bearing MCP1 fragments with mCherry targeted to 
the ER or mitochondria were constructed using the Gibson Assembly 
cloning kit (New England Biolabs). To generate the plasmid bearing 
GFP-tagged Vps13 after aa 499, the pSOI1 plasmid (Brickner and 
Fuller, 1997) bearing the full-length VPS13 sequence was digested 
and gap-repaired in a yeast strain bearing the GFP-tagged VPS13 in 
the genome (Lang et al., 2015).
Growth assay
Cells were grown in yeast extract peptone dextrose or minimal medium 
to mid-log phase, diluted to 0.25 OD600, spotted on appropriate plates, 
and grown at RT or 37°C. Fivefold serial dilutions were made, with the 
first spot in each row corresponding to 2.5 µl of 0.25 OD600.
PK accessibility assay
Mitochondria were isolated from yeast cells expressing either 
Mcp1-HA or Mcp1 by differential centrifugation as described before 
(Daum et al., 1982). Mitochondria (50 µg) were treated with increasing 
amounts (2–200 µg/ml) of PK in the absence or presence of 1% Triton 
X-100. Samples were analyzed using SDS-PAGE followed by Western 
blot analysis with antibodies against Mcp1, the HA tag, or the indicated 
mitochondrial proteins.
GFP immunoprecipitation
Approximately 1,500 OD units of cells grown overnight in yeast ex-
tract peptone dextrose were resuspended in 2 ml TNG buffer (50 mM 
Tris, pH 7.4, 100 mM NaCl, and 5% glycerol) together with protease 
inhibitors pepstatin and aprotinin at a final concentration of 1 µg/ml. 
Glass beads were added, and cells were lysed using a Disrupter Genie 
(Scientific Industries) for 10 min at 4°C. The lysate was centrifuged 
at 13,000 g for 5 min, and the supernatant was collected. To the pellet, 
700 µl of TNG buffer with 1% NP-40 was added, resuspended, and 
left on a nutator at 4°C for 30 min. After centrifugation, the superna-
tants were pooled, and the protein amount was estimated. 20 µl GFP–
TrapA beads (ChromoTek) were added and left on a nutator at 4°C for 
4 h. After washing the beads (50 mM Tris, pH 7.4, 400 mM NaCl, and 
5% glycerol), bound proteins were eluted with 1× Laemmli buffer with 
incubation at 42°C for 15 min.
Fluorescence microscopy
Cells were grown to mid-log phase in complete synthetic dextrose 
(SD) medium or SD–uracil (for selection for mitochondrial blue flu-
orescent protein plasmid) or SD–uracil–leucine (for selection of mi-
tochondrial blue fluorescent protein and the Vps13^GFP plasmids). 
Images were acquired using a DeltaVision MPX microscope (Applied 
Precision) equipped with a 100× 1.40 NA oil UplanS-Apo objective 
lens (Olympus), a multicolor illumination light source, and a Cool-
SNA PHQ2 camera (Roper Scientific). Image acquisition was done 
at RT. Images were deconvolved with SoftWoRx software using the 
manufacturer’s parameters. Images were processed further using FIJI 
ImageJ bundle and assembled on Adobe Illustrator CS6. A single 
Z-section is depicted in the figures unless otherwise mentioned. For 
vacuolar staining, cells were pulsed with FM4-64 (Molecular Probes) 
at a concentration of 5 µg/ml for 20 min in the dark at 30°C. After 
washing, cells were chased for another 20 min in medium without 
FM4-64 and imaged subsequently. Quantification of colocalization 
was performed automatically in ImageJ (see the scripts in the online 
supplemental material).
Bioinformatics analyses
Hidden Markov model homology searches were performed using 
HHpred software (Söding et al., 2005). Homology modeling was 
performed using the Swiss-Model server (Biasini et al., 2014). 
3D protein structures were rendered using tCHI MERA software 
(Pettersen et al., 2004).
Online supplemental material
Fig. S1 shows that Pex10 and Vps38 do not colocalize. Fig. S2 shows 
that the Vps13 suppressor rescues loss of ERM ES function in the ab-
sence of Vps38. Yeast strains, plasmids, and primers used in the study 
are listed in Tables S1, S2, and S3, respectively. Alignments S1 and 
S2 show homology search results for Vps13 (1–3,000 aa) and Vps13 
(1,501–3,144 aa), searched against the Pfam database and yeast pro-
teome, respectively. Alignments S3 and S4 show the results for the C 
terminus of Vps13 (3,030–3,144 aa) and full-length Mcp1, respectively, 
searched against the Protein Data Bank. All homology alignments were 
generated using the HHPred server. Scripts S1, S2, and S3 are ImageJ 
macros used to calculate the percentage of colocalization between 
Vps13^GFP/Pex10-mCherry foci, Vps13^GFP/Vps38-mCherry foci, 
and Pex10-GFP/Vps38-mCherry foci, respectively.
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Abstract 23 
The yeast protein Taz1 is the orthologue of human T fazzin, a phospholipid acyltransferase 24 
involved in cardiolipin (CL) remodeling via a monolyso CL (MLCL) intermediate. Mutations 25 
in Tafazzin lead to Barth syndrome (BTHS), a metabolic and neuromuscular disorder that 26 
primarily affects the heart, muscles, and immune system. Similar to observations in fibroblasts 27 
and platelets from patients with BTHS or from animal models, abolishing yeast Taz1 results in 28 
decreased total CL amounts, increased levels of MLCL, and mitochondrial dysfunction. 29 
However, the biochemical mechanisms underlying the mitochondrial dysfunction in BTHS 30 
remain unclear. To better understand the pathomechanism of BTHS, we searched for multi-31 
copy suppressors of the taz1Δ growth defect in yeast cells. We identified the branched-chain 32 
amino acid transaminases (BCATs) Bat1 and Bat2 as such suppressors. Similarly, 33 
overexpression of the mitochondrial isoform BCAT2 in mammalian cells lacking TAZ improves 34 
their growth. Elevated levels of Bat1 or Bat2 did not restore the reduced membrane potential, 35 
altered stability of respiratory complexes, or the defective accumulation of MLCL species in 36 
yeast taz1Δ cells. Importantly, supplying yeast or mammalian cells lacking TAZ1 with certain 37 
amino acids restored their growth behavior. Hence, our findings suggest that the metabolism of 38 
amino acids has an important and disease relevant role in cells lacking Taz1 function. 39 
 40 
Keywords: Barth syndrome / cardiolipin / mitochondria / Tafazzin / TAZ1 /  41 
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Introduction 52 
Mitochondria are essential organelles that fulfil crucial roles in cellular bioenergetics, 53 
apoptosis, and metabolism of amino acids, lipids, nucleic acids, and heme. To properly carry 54 
out all these functions, mitochondria have to maintain their unique protein and lipid 55 
composition. Of the mitochondrial lipids, cardiolipin (CL) comprises the signature dimeric 56 
phospholipid (PL) for this organelle. CL interacts with several inner membrane (IM) protein 57 
complexes affecting the structure and activity of respiratory supercomplexes and ultimately the 58 
oxidative generation of ATP (Pfeiffer et al., 2003; Zhang et al., 2005). In addition, CL has been 59 
implicated in the biogenesis of outer membrane proteins (Gebert et al., 2009; Sauerwald et al., 60 
2015).  61 
After its initial synthesis, CL undergoes acyl chain remodeling that replaces the pre-existing 62 
fatty acids with other ones, which are organism and tissue specific (Schlame et al., 2005). This 63 
reaction is catalysed by the enzyme TAZ (Tafazzin) that encodes a phospholipid transacylase, 64 
which is highly conserved from yeast to human. Mutations in the tafazzin gene are associated 65 
with a number of clinical disorders including Barth syndrome (BTHS).  66 
BTHS is a rare X-linked disease characterized by skeletal myopathy and cardiomyopathy, and 67 
in some cases neutropenia. Although three CL remodeling pathways have been identified in 68 
higher eukaryotes, TAZ1 is the only transacylase that mediates such remodeling in yeast cells 69 
(Claypool and Koehler, 2012). Loss of Taz1 leads to a decrease in the total cellular amounts of 70 
CL, accumulation of monolyso-cardiolipin (MLCL, CL lacking one acyl chain), and aberrant 71 
CL species (Gu et al., 2004). Similar alterations were also observed in fibroblasts and platelets 72 
obtained from either patients with BTHS or animal models (Schlame et al., 2002; Valianpour 73 
et al., 2002; Vreken et al., 2000). Despite the aforementioned CL-related disturbances, it was 74 
reported that the major phenotypes of yeast cells lacking TAZ1 are mainly due to the increased 75 
ratio MLCL/CL rather than the absence of modified CL (Baile et al., 2014; Ye et al., 2014). In 76 
addition to the altered CL composition, a multitude of various mitochondrial defects is observed 77 
in cells lacking TAZ1. Mitochondria of yeast taz1Δ cells also exhibit a decreased membrane 78 
potential and increased proton leak (Baile et al., 2013). Such a hampered proton-motive force 79 
across the IM aggravates mitochondria function and the organelles are then prone to oxidative 80 
damage by the increased production of reactive oxygen species (ROS).     81 
One of the main metabolic pathways that takes place inside mitochondria is the tricarboxylic 82 
acid (TCA) cycle, which is crucial for providing reductive equivalents to the respiratory chain 83 
complexes. In cells defective for TAZ1, the ATP production via oxidation of NADH is 84 
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compromised, resulting in a decreased NAD+/NADH ratio (Gonzalvez et al., 2013). As a 85 
consequence of the NADH accumulation, metabolic dysfunctions such as inhibition of TCA 86 
cycle enzymes that require NAD+ occur and subsequently, the TCA cycle activity halts (Ikon 87 
and Ryan, 2017; Vatrinet et al., 2017).  88 
Although TAZ mutations have been clearly implicated in BTHS, the precise role and the 89 
involvement of this protein in the pathomechanism of the disease has remained elusive. To 90 
address this issue, we screened for multi-copy suppressors of the taz1Δ growth defect in yeast 91 
cells and identified the branched-chain amino acid transaminases (BCATs), Bat1 and Bat2, as 92 
such suppressors. Accordingly, we found that altered metabolism of amino acids likely play an 93 
important and disease relevant role in human cells lacking TAZ. Collectively, our findings 94 
provide insights to the pathomechanism of the TAZ-mediated Barth syndrome. 95 
 96 
 97 
 98 
Results  99 
Identification of multi-copy suppressors for impaired growth of taz1Δ cells 100 
Yeast cells provide a reliable model system to study the pathomechanism of BTHS. The 101 
deletion of TAZ1 does not lead to observable growth defects on synthetic medium containing a 102 
fermentable carbon source like glucose (SD) or non-fermentable ones like glycerol or acetate 103 
(SG or SA, respectively). In contrast, cells lacking Taz1 grow poorly when ethanol is the sole 104 
carbon source (Fig. 1A, SE-Leu). This growth defect can be reversed upon expression of TAZ1105 
from a plasmid (Fig. 1A), suggesting that the absence of Taz1 is the primary reason for this 106 
defect. To better understand the molecular mechanisms involved in this phenotype, we searched 107 
for gene targets whose overexpression suppress the growth defect of taz1Δ cells. For this 108 
purpose, we transformed taz1Δ cells with a yeast genomic library cloned in a high copy number 109 
(2μ based) yeast expression vector (Stettler et al., 1993; Tan et al., 2013). Transformants were 110 
initially grown on selective medium lacking uracil (SD-Ura) to select for those containing the 111 
plasmid and then replica-platted several times on plates containing ethanol (SE-Ura), condition 112 
where taz1Δ cells do not grow. Clones able to grow on ethanol as the sole carbon source were 113 
considered as those harbouring potential suppressors (Fig. 1B). To ensure saturation, we 114 
screened 55,000 colonies and identified several clones that exhibited rescue of the growth 115 
defect.  116 
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One of the identified clones contained the TAZ1 open reading frame (ORF) (data not shown), 117 
confirming the validity of the screen. The remaining plasmids harboured DNA fragments 118 
mostly co-encoding for CRG1, COX24, HMX1, and BAT1 (Fig. 1B, #16 and #29). CRG1 119 
encodes for a methyltransferase involved in lipid homeostasis, Cox24 is a translation modulator 120 
of COX1 mRNA, and Hmx1 is an ER heme oxygenase, whereas BAT1 encodes for a 121 
mitochondrial branched-chain amino acid transaminase (BCAT) (Kispal et al., 1996). To verify 122 
the potential of these genes to complement the growth defect, they were genomically 123 
overexpressed in taz1Δ cells under the control of the strong GPD promoter. Growth assessments 124 
of the four initial candidates demonstrated that only BAT1 overexpression was able to 125 
reproducibly rescue the taz1Δ growth defect (Fig. 1C, D). Since Bat1 has a highly homologous 126 
protein, Bat2, which shares the same function but is located in the cytosol (Kispal et al., 1996), 127 
we analysed whether the overexpression of BAT2 can also complement the growth defect of 128 
taz1Δ cells. Indeed, the overexpression of BAT2 rescues the growth defect of taz1Δ cells, though 129 
not as efficient as the overexpression of BAT1 (Fig. 1D).  130 
Western blotting analysis verified that indeed Bat1 and Bat2 are detected in higher levels in the 131 
overexpressing strains. Given the high sequence homology between Bat1 and Bat2, the 132 
antibody raised against Bat1 also recognises Bat2. Interestingly, it appears that Bat1 levels are 133 
decreased in bat2Δ cells (Fig. S1). 134 
The rescue of the growth defect of taz1Δ cells by BAT1 or BAT2 overexpression suggests a 135 
functional compensation related to the defective CL remodeling process. To address whether 136 
the observed compensation can be also extended to the loss of CL, we analysed the growth of 137 
cells deficient for CL due to deletion of key enzymes in its biosynthesis pathway, GEP4 and 138 
CRD1. These mutant cells have a severe growth defect when incubated at elevated temperatures 139 
on non-fermentable carbon sources. In contrast to the situation with taz1Δ cells, we did not 140 
observe rescue of the growth defects of cells lacking CL biosynthetic enzymes upon BCATs 141 
overexpression (Fig. 1E). These results indicate that enhanced metabolism of amino acids can 142 
compensate for defects specifically related to CL remodeling but not to its absence. 143 
     144 
BCATs-mediated rescue of the retarded growth of taz1Δ cells is not associated with repair 145 
of mitochondrial defects in these cells 146 
CL is known to stabilize the electron transport chain supercomplexes (Bazan et al., 2013; 147 
McKenzie et al., 2006; Zhang et al., 2005). Accordingly, the formation of supercomplexes 148 
harbouring complexes III and IV is altered in mitochondria lacking Taz1 (Baile et al., 2014; 149 
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Brandner et al., 2005) (Fig. 2A, B). To understand better the relevance of BCATs for the rescue 150 
of taz1Δ growth defect, we investigated whether their overexpression could restore this altered 151 
assembly. Upon analysing complexes assembly by blue native (BN)-PAGE, we found that 152 
overexpression of neither BAT1 nor BAT2 reverted the defects caused by loss of Taz1 to the 153 
respiratory chain complexes (Fig. 2A, B). More generally, loss of Taz1 leads to reduced 154 
membrane potential (ΔΨ) by ~30%, as compared to WT mitochondria (Brandner et al., 2005). 155 
Overexpression of BCATs did not restore the reduced ΔΨ of mitochondria isolated from taz1Δ 156 
cells, as monitored with the membrane potential-sensitive dye 3,3’-157 
diprophylthiadicarbocyanine iodide (DiSC3(5)) (Fig. 2C).  158 
Next, we measured the oxygen consumption of mitochondria isolated from either control (WT) 159 
or taz1Δ cells. Interestingly, mitochondria of the mutant cells had higher consumption rate, 160 
maybe in an attempt to compensate their compromised function. The overexpression of BAT1161 
or BAT2 in taz1Δ cells revert the oxygen consumption to WT levels (Fig. S2A). Hence, BAT1/2 162 
can affect respiration without correcting the ΔΨ and the respiratory chain supercomplexes 163 
assembly. As a comparison, deleting the TCA enzyme Fumarase, resulted also in enhanced 164 
oxygen consumption whereas, as expected, the absence of the mitochondrial inner membrane 165 
insertase Oxa1 led to highly reduced respiration (Fig. S2B).  166 
We wondered if the capacity to affect the respiration resulted from a rescue in lipid content. A 167 
major consequence of the loss of Taz1 function is a decrease in the amounts of CL and 168 
accumulation of MLCL species (Xu et al., 2016). Therefore, we investigated by thin layer 169 
chromatography (TLC) the effect of BAT1/2 overexpression on the phospholipid profile of 170 
mitochondria isolated from taz1Δ cells. As expected, a MLCL accumulation and CL reduction 171 
was observed in taz1Δ mitochondria. However, taz1Δ cells with higher levels of Bat1 or Bat2 172 
did not rescue this altered PLs profile (Fig. 2D). This suggests that recovery of respiration 173 
behavior is not through a rescue of lipid homeostasis but through a bypass mechanism. In 174 
accordance with this notion, we found that overexpression of BAT1/2 does not affect the steady 175 
state levels of proteins residing in the various mitochondrial sub-compartments (Fig. 2E).  176 
 177 
Amino acids supplementation rescues the growth defect of taz1Δ cells 178 
Bat1 and Bat2 are branched-chain amino acid aminotransferases that catalyze the conversion 179 
of branched-chain amino acids (BCAAs) and α-ketoglutarate into branched chain α-keto acids 180 
and glutamate. We next asked whether supplementation of BCAAs to the medium could rescue 181 
the growth retardation of taz1Δ cells. Indeed, supplementation of valine rescued the growth 182 
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defect of taz1Δ cells in a dose-dependent manner (Fig. 3A). However, the addition of the two 183 
other BCAAs, leucine (Fig. S3A) or isoleucine (Fig. S3D) did not result in improved growth of 184 
taz1Δ cells. Along the same lines, overexpression of the LEU2 gene, which encodes a key 185 
enzyme in the biosynthesis pathway of leucine, in the mutated cells did not rescue the growth 186 
defect (Fig. S3B). Since the BCAT enzymes can catalyze the conversion between keto acids 187 
and amino acids in both directions, we also tested whether the corresponding keto acid form of 188 
leucine, alpha-ketoisocaproic acid (KIC), might have a beneficiary effect for taz1Δ cells. 189 
However, addition of this molecule to the solid medium did not improve the growth of the 190 
mutated cells (Fig. S3C).  191 
To test whether other amino acids can rescue the defects of Taz1-deficient cells, we 192 
supplemented ethanol-containing plates with aspartate. Of note, the growth defect of taz1Δ cells 193 
was largely rescued upon supplementation with aspartate (Fig. 3B). To investigate if the 194 
observed rescue of the growth defect is related to the CL profile of these cells, we analysed the 195 
profile of PLs of isolated mitochondria from taz1Δ cells grown in the absence or presence of 196 
either aspartate or valine (Fig. 3C). Our results revealed that supplementation of taz1Δ cells 197 
with both amino acids did not restored the defective MLCL/CL ratio characteristic for these 198 
mutated cells.  199 
We expanded our analysis also to supplementation with either glutamate or histidine. Whereas 200 
the former amino acid only rescues partially the decreased growth of taz1Δ cells (Fig. 3D), 201 
addition of histidine to the medium could fully restore the growth deficit of taz1Δ cells (Fig. 202 
3E). Taken together, these results show that the Bat1/2-mediated rescue of Taz1-depleted cells 203 
can be explained by elevated cellular levels of some amino acids. Our findings that elevated 204 
levels of BCATs or supplementation of certain amino acids can rescue the growth defect of 205 
taz1Δ cells led us to investigate whether enhanced transport of amino acids from the vacuole 206 
(yeast lysosome) to cytosol can have a similar effect. To that aim, we overexpressed two 207 
vacuolar amino acid transporters AVT1 and AVT4 in the mutated cells. However, such 208 
overexpression did not improve the growth of taz1Δ cells (Fig. 3F). 209 
  210 
Increased levels of TCA cycle metabolites and amino acids in taz1Δ cells with elevated 211 
amounts of Bat1 212 
The previous results suggested that overexpression of BCATs or supplementation of amino 213 
acids like valine, aspartate, glutamate, or histidine can rescue the growth defects of taz1Δ cells. 214 
Hence, next we tested whether the levels of these amino acids or metabolites of the TCA cycle 215 
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are actually altered in the deletion cells and if the overexpression of BCATs changes their 216 
levels. To that end, we grew the cells in 2% ethanol, extracted metabolites from yeast cells and 217 
monitored their levels by liquid chromatography coupled with mass spectrometry (LC-MS). 218 
The amounts of most of the TCA cycle intermediates were reduced in taz1Δ cells (Fig. 4). Yet, 219 
we did not observe a restored growth of taz1Δ cells upon supplementation of TCA metabolites 220 
(Fig. S4). Importantly, we observed that BAT1 overexpression restores and even greatly 221 
increased the levels of most of the TCA metabolites and of the beneficial amino acids like valine 222 
and histidine (Fig. 4). In agreement with its reduced rescue capacity, overexpression of BAT2 223 
did not have a significant effect on the levels of these metabolites (Fig. 4). These results support 224 
the notion that reduced levels of certain amino acids can contribute to the cellular defects in 225 
taz1Δ cells and replenishing these metabolites can rescue the growth retardation of these cells. 226 
   227 
Overexpression of mammalian BCATs or valine supplementation enhances the 228 
proliferation of Tafazzin-deficient mouse embryonic fibroblasts  229 
The aforementioned results were obtained with a yeast model of BTHS. To generalize our 230 
hypothesis and substantiate our findings, we turned to mammalian cells. We employed our 231 
previously described mouse embryonic fibroblasts (MEFs) where Tafazzin was knocked-out  232 
(TAZ-/-) (Chowdhury et al., 2018). We found that the overexpression of the mammalian 233 
mitochondrial isoform BCAT2, (Bledsoe et al., 1997), provide a significant increment of 234 
proliferation for cells lacking TAZ (Fig. 5A). In contrast, elevated levels of the cytosolic form, 235 
BCAT1 had only minor effect on the growth of the mutated cells. Of note, overexpressing 236 
BCATs in WT cells did not influence the growth of these cells (Fig. 5A). Next, we sought to 237 
test the effect of valine supplementation on proliferation of TAZ-/- cells and observed a major 238 
enhancement already at rather low concentrations of valine supplementation (1 mM) (Fig. 5B). 239 
Analysis of growth after 72 hrs revealed that the addition of valine to the growth medium 240 
resulted in a 3-fold increase in cell proliferation of the mutant cells whereas that of control cells 241 
was increased only slightly. These findings indicate that the ability to rescue the growth of TAZ 242 
mutant by either overexpression of mitochondrial BCAT or by supplementation of certain 243 
amino acids is conserved from yeast to mammalian cells. 244 
 245 
 246 
 247 
 248 
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Discussion 249 
The deletion of TAZ1 leads to a severe growth phenotype of yeast cells on synthetic medium 250 
using the non-fermentable carbon source ethanol as the sole carbon source. Of note, these 251 
mutant cells grow normally on non-fermentable carbon sources like glycerol or acetate 252 
suggesting that compromised respiration is not the main problem of these cells. Indeed, our 253 
results suggest increased respiration in these cells. The sensitivity of the taz1Δ mutant to ethanol 254 
is consequential of the decreased CL levels and altered acyl composition of this crucial dimeric 255 
PL. As previously reported, ethanol-tolerance of mutants in yeast depends on their lipid 256 
composition andunsaturation degree (Chi and Arneborg, 1999). Mitochondrial damage occurs 257 
upon ethanol stress via inactivation of some mitochondrial enzymes and increased production 258 
of ROS (Costa et al., 1997; Du and Takagi, 2007; Jimenez and Benitez, 1988). In fact, it has 259 
been shown that in taz1Δ cells grown in ethanol, the carbonylation levels of proteins - an260 
indicative of increased ROS - are double than those of cells grown on glucose (Chen et al., 261 
2008). Thus, the various compromised mitochondrial functions in taz1Δ cells aggravate their 262 
ethanol sensitivity. 263 
In the current study, we report on BCATs as specific suppressors of the growth defects of both 264 
yeast and mammalian cells lacking Taz1 or TAZ, respectively. We identified this new property 265 
for Bat1 and Bat2 while searching for high-copy suppressors of the growth phenotype of yeast 266 
taz1Δ cells. Despite its reasonable growth phenotype suppression capacity, the cytosolic protein 267 
Bat2 was not identified in the multi-copy suppressor screen, probably due to incomplete 268 
coverage of the used genomic library. Of note, the overexpression of BCATs could not rescue 269 
the growth defects of cells lacking CL all together, suggesting that the products of their 270 
enzymatic activities cannot complement the absence of this unique PL. Both BCATs were 271 
reported previously to affect directly or indirectly several cellular processes. For example, 272 
BAT1, but not BAT2, was identified as a high-copy suppressor of a temperature-sensitive 273 
mutation in ATM1, encoding a mitochondrial ABC transporter (Kispal et al., 1996). Recently, 274 
both yeast BCAT homologs have been implicated to be critical for the activation of TORC1 275 
signalling (Kingsbury et al., 2015). Hence, these aforementioned observations together with our 276 
current findings that supplementation of taz1Δ cells with amino acids reversed their 277 
compromised proliferation, suggest that enhanced metabolism of amino acids might 278 
compensate for other cellular dysfunctions. 279 
Overexpression of the BCATs does not restore mitochondrial defects reported for az1Δ cells 280 
like altered assembly of respiratory complexes, increased MLCL/CL ratio, or reduced 281 
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membrane potential. On the other hand, such overexpression increases the levels of some TCA 282 
metabolites. Hence, our findings suggest that the major contribution of BCATs is probably 283 
through a compensatory increase in the flux of the TCA cycle. Interestingly, the growth defect 284 
rescue in both yeast and mammalian cells with the two different BCAT isoforms was similar. 285 
In both cell types, the mitochondrial isoform had a higher rescue capacity. Hence, although the 286 
mitochondrial and cytosolic isoforms have overlapping functions in transamination reactions, 287 
it appears that their products are required more in mitochondria and that they are not completely 288 
free to equilibrate between the matrix of mitochondria and the cytosol.  289 
An interesting question is why only valine among the BCAAs and other amino acids like 290 
aspartate or histidine displayed rescue activity on taz1∆ cells. Obviously, it is hard to determine 291 
how much of the externally added metabolites are actually transported across the cell wall, 292 
plasma membrane and into the mitochondrial matrix. Hence, we cannot exclude the obvious 293 
possibility that differences in rescue ability reflect (at least partially) variations in the 294 
transported amounts (and hence effective concentrations) of the different molecules. An 295 
alternative explanation is that in contrast to the two other BCAAs, valine degradation products 296 
can be fed directly into the TCA cycle, leading to a faster replenishment of the cellular energy 297 
demands.  298 
Currently, despite the obvious link to the TCA cycle, the mechanism by which overexpression 299 
of BCATs, and elevated levels of certain amino acids, rescue the growth defects of cells lacking 300 
Taz1 is not completely clear. One possibility is that the enhanced levels of either amino acids 301 
or TCA metabolites can serve as replenishment for amino acids or metabolites, which formation 302 
is compromised in taz1∆ cells. An alternative, but not mutual exclusive possibility, is that the 303 
backbones of these amino acids, which contain more than two carbons (in contrast to ethanol), 304 
are used for general carbon anabolic pathways (like gluconeogenesis). 305 
In addition, beneficial effects of amino acids were reported in several related contexts. For 306 
example, dietary supplementation of BCAAs has been implied to protect against ethanol 307 
toxicity by reverting structural and functional mitochondrial damages in rodents with alcoholic 308 
liver disease (Tedesco et al., 2018). A link between impaired CL remodeling and amino acids 309 
metabolism is further supported in a TAZ  knock-down mouse model in which the increased 310 
MLCL/CL ratio led to a substrate shift via de novo amino acid biosynthesis as well as amino 311 
acid usage by the TCA cycle (Kiebish et al., 2013). Additionally, Bat1 was reported to interact 312 
with the TCA cycle enzyme Aconitase. The recent identification of yeast oxodicarboxylate 313 
carrier (Odc1) as another factor that can rescue defects of taz1∆ cells (de Taffin de Tilques et 314 
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al., 2017) further support the link between amino acids metabolism and taz1∆ phenotypes. Odc1 315 
is involved in glutamate and lysine biosynthesis by its function as a transporter of several TCA 316 
cycle intermediates across the mitochondrial IM (Palmieri et al., 2001). Elevated levels of Odc1 317 
were reported to fully restore the oxidative phosphorylation and growth defects in taz1∆ yeast 318 
(de Taffin de Tilques et al., 2017).  319 
Furthermore, mutation of BCATs resulted in perturbed TCA-cycle intermediate levels, which 320 
in turn led to reduced ATP levels and inhibition of TORC1 (Kingsbury et al., 2015). Another 321 
evidence for the potential relevance of CL for the TCA cycle emerges from a recent study 322 
showing that yeast cells deleted for CL synthase (crd1Δ), and hence are CL-deficient, have 323 
decreased acetyl-CoA levels, decreased activity of acetyl-CoA synthetase, and consequently, 324 
deficiencies in the TCA cycle. These defects were reflected in decreased growth on medium 325 
containing acetate as the sole carbon source (Raja et al., 2017). Interestingly, the taz1Δ strain 326 
displays no growth defect on acetate media, a phenotype that is characteristic for many yeast 327 
mutants bearing disruptions in genes encoding TCA cycle enzymes (Minard and McAlister-328 
Henn, 2009). Thus, although we observed lower levels of some TCA cycle metabolites in az1Δ329 
cells, it is unclear to which extent the TCA cycle is compromised in thesecell .  330 
Naturally, one cannot exclude the contribution of peroxisomes in providing new TCA cycle 331 
intermediates by β-oxidation or the glyoxylate cycle (Elgersma et al., 1995). Yet, we propose 332 
that peroxisomal function is not related to the phenotypes of taz1Δ cells since these cells grow 333 
normally on medium containing oleic acid as the sole carbon source (data not shown), 334 
conditions where yeast cells rely on functional peroxisomes. Collectively, we suggest that 335 
elevated levels of certain amino acids can enhance cellular growth either directly upon their 336 
conversion to TCA intermediates and increased flux of this pathway or indirectly by their 337 
induction of the mTOR signalling pathway. Taken together, we show here that yeast and 338 
mammalian cells lacking CL remodeling benefit from the overexpression of BCATs and valine 339 
supplementation. As such, this work proposes that the metabolism of amino acids has an 340 
important and disease relevant role in such mutated cells and highlights the potential usage of 341 
some amino acids as a therapeutic avenue to help alleviate some of the symptoms of patients 342 
with Barth syndrome.  343 
 344 
 345 
 346 
 347 
 348 
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Materials and methods 349 
Yeast strains and growth conditions       350 
The wild type Saccharomyces cerevisiae W303a/α or BY4741 strains were utilized. Cells were 351 
transformed using the Li-acetate method (Gietz and Woods, 2006; Janke et al., 2004; Longtine 352 
et al., 1998). Genomic overexpression was performed by homologous recombination replacing 353 
the endogenous promoter by the constitutive promoter GPDpr (Janke et al., 2004). Primers for 354 
these replacements and their validation were designed using the Primers-4-Yeast toolkit  (Yofe 355 
and Schuldiner, 2014). To delete complete ORFs by homologous recombination, the HIS3MX6 356 
cassette was amplified from the plasmid pFA6a-HIS3MX6 (Wach et al., 1997) with gene-357 
specific primers. Yeast strains used in this study are described in Table S1. Yeast strains were 358 
grown in rich YP medium (2% [w/v] bactopeptone, 1% [w/v] yeast extract) containing various 359 
carbon sources, in lactate medium (0.3% [wt/vol] yeast extract, 0.5 g/l glucose, 0.5 g/l NaCl, 1 360 
g/l KH2PO4, 1 g/l NH4Cl, 0.6 g/l MgCl2, 0.5 g/l CaCl2, 2% [vol/vol] lactic acid, pH 5.5), as 361 
well as in synthetic (S) medium (0.67% [w/v] bactoyeast nitrogen base without amino acids) 362 
with glucose (2% [w/v], D), lactate (2% [w/v], Lac), or ethanol (2% [w/v], E) as carbon source. 363 
For drop dilution assays, cells were cultured to logarithmic phase, collected by centrifugation, 364 
and resuspended in water to an OD600 of 2.0. Cell suspensions were serially diluted fivefold in 365 
water and 5 µl of each cell suspension were spotted on the appropriate solid medium followed 366 
by incubation at either 30°C or 37°C. In some cases, the indicated concentrations of the 367 
specified metabolite were added to SE solid medium. 368 
 369 
Recombinant DNA techniques 370 
The open reading frame of TAZ1 was amplified by PCR from WT yeast genomic DNA and 371 
cloned into the plasmid pYX142 using EcoRI and HindIII restriction sites. The construct was 372 
verified by DNA sequencing. A list of all plasmids and primers used in this study is included 373 
in Table S2. 374 
 375 
Multi-copy suppressor screening  376 
Electro-competent yeast cells lacking Taz1 (taz1Δ) were transformed with a high-copy-number 377 
yeast genomic library in the URA3 2µ plasmid pFL44L (Stettler et al., 1993). To select for 378 
transformants, cells were initially grown at 30°C on SD lacking uracil (SD-Ura). Then, clones 379 
were replica plated several times on SE medium and further incubated at 30°C. Plasmid DNA 380 
was extracted from clones that grew under these conditions and transformed into E.coli cells. 381 
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Plasmids were obtained from the transformed E. coli cells and their capacity to rescue the 382 
growth defect of taz1Δ cells was confirmed. The DNA inserts of isolated verified plasmids were 383 
identified by sequencing. 384 
 385 
Biochemical methods        386 
Mitochondria were isolated from yeast cells grown to logarithmic phase in either lactate or S-387 
lactate medium and harvested by differential centrifugation as described (Daum et al., 1982). 388 
To analyze the steady state levels of mitochondrial proteins, isolated organelles were subjected 389 
to 12.5% or 10% SDS-PAGE and proteins were transferred onto nitrocellulose membranes by 390 
semi-dry western blotting. Proteins were immunodecorated with primary antibodies and the 391 
detection was performed with horseradish peroxidase-coupled secondary antibody. A list of 392 
primary antibodies used in this study is included in Table S3.  393 
Blue Native (BN)-PAGE was performed as described before (Schagger, 2002). Briefly, 394 
mitochondria were solubilised in 40 µl buffer containing digitonin (1% digitonin, 20 mM Tris-395 
HCl, 0.1 mM EDTA, 50 mM NaCl, 10% (v/v) glycerol, 1 mM PMSF, pH 7.2). After incubation 396 
on ice for 15 min and clarifying spin (30,000g, 15 min, 2°C), 5 µl sample buffer (5% (w/v) 397 
Coomassie blue G, 500 mM 6-amino-N-caproic acid, 100 mM Bis-Tris, pH 7.0) was added. 398 
The native complexes were analyzed by electrophoresis in a 6-14% gradient of acrylamide BN-399 
PAGE gel. Gels were blotted on polyvinylidene fluoride membranes and proteins were further 400 
analyzed by immunodecoration. 401 
 402 
Monitoring membrane potential of isolated mitochondria  403 
The membrane potential across the mitochondrial inner membrane (ΔΨ) was monitored by 404 
fluorescence quenching of a ΔΨ-sensitive dye by adapting a published method (Gartner et al., 405 
1995). Briefly, DiSC3(5) (final concentration of 2 µM) was added to 3 ml buffer containing 406 
(0.6 M sorbitol, 0.1% (w/v) fatty acid-free BSA, 0.5 mM EDTA, and 20 mM KPI, pH 7.2. The 407 
fluorescence was monitored with excitation at 622 nm and emission at 670 nm, and data points 408 
were taken at 2 sec intervals. Once the fluorescence signal was stabilized, 50 µg of isolated 409 
mitochondria were added to the cuvette, and the fluorescence intensity was further monitored 410 
until a stable signal was obtained. Finally, to completely dissipate the membrane potential, 411 
valinomycin (final concentration 1 µM) was added to the mixture, and the increase in the 412 
fluorescence intensity was recorded. Membrane potential was assessed as the difference 413 
between the fluorescence signal before and after the addition of valinomycin. 414 
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Mitochondrial oxygen consumption assay 415 
The rate of oxygen consumption of isolated mitochondria was measured polarographically at 416 
25°C using a Clark-type oxygen electrode connected to a computer-operated Oxygraph control 417 
unit (Hansatech Instruments, Germany). Isolated mitochondria (100 µg) suspended in a buffer 418 
containing 0.6 M sorbitol, 20 mm Hepes (pH 7.4), 1 mM EDTA and 1 mm MgCl2 were added 419 
to the oxygen chamber with continuous stirring. Respiration was initiated by the addition of 420 
NADH (final conc. 7 mM) and recorded at sampling intervals of 1 sec (Oxygraph Plus software, 421 
Hansatech Instruments).  422 
 423 
Extraction and analysis of mitochondrial phospholipids 424 
Lipid extraction of isolated mitochondria was performed according to published method (Bligh 425 
and Dyer, 1959). Briefly, a mixture of chloroform:methanol 1:2 (v/v) was added to 600 µg of 426 
mitochondria , vortexed, and incubated on ice for 30 min. Then, 1.25 times (v/v) of chloroform 427 
and water were added and after vigorous vortex, samples were centrifuged (1000 g, 5 min, RT). 428 
The organic phase was collected and solvents were evaporated by speed vac. Then, lipids were 429 
resuspended in 40 µL of chloroform:methanol 1:1 (v/v) mixture and either stored at -20°C or 430 
immediately used.  431 
Phospholipid (PL) classes from the total lipid extract were separated by thin-layer 432 
chromatography (TLC) using glass plates of pre-coated 0.25 mm silica gel with fluorescent 433 
indicator UV254. Prior to separation, the silica plates were washed with a mixture of 434 
chloroform:methanol 1:1 (v/v) and dried for 15 min. Then, plates were sprayed with a solution 435 
of 2.3% (v/v) boric acid in ethanol and dried in an oven at 100°C for 15 min. Next, 40 µL of 436 
sample of total lipid extract or 3-5 µL of PL standards were applied to the plate. The spots were 437 
air dried and developed in a solvent mixture of chloroform/ethanol/water/trimethylamine 438 
(30:35:7:35, v/v/v/v). After complete migration and eluent evaporation, the TLC plates were 439 
sprayed with molybdenum blue solution. Identification of the different classes of PLs was 440 
performed out by comparison with the migration behavior of PL standards. 441 
 442 
Analysis of yeast metabolites by mass spectrometry 443 
Pellets of yeast cells were lyophilized followed by homogenization with a ball mill. Metabolites 444 
were first extracted with 400 µl of 80% methanol containing 0.1% formic acid and afterwards 445 
re-extracted with 400 µl of 20% methanol containing 0.1% formic acid. Both supernatants were 446 
combined and dried in a speed-vac concentrator. Samples were re-dissolved in 120 µl of 20% 447 
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methanol containing 0.1% formic acid and 7 µl were injected onto a Waters Acquity HSST3 448 
2.1x100 mm, 1.8 µm ultra-performance liquid chromatography (UPLC) column. Separation 449 
was carried out with an isocratic 2 min step of 99% water containing 0.1% formic acid, followed 450 
by a linear 10 min gradient to 99% methanol (containing 0.1% formic acid) at a flow rate of 451 
200 µl/min.  The analysis was conducted with a Waters Acquity UPLC - SynaptG2 LC/MS 452 
system operated in positive and negative electrospray ionization mode with a scan range of 50-453 
2000 m/z at a scan rate of 0.5 sec. For relative quantification of the metabolites, extracted ion 454 
traces were generated and integrated. 455 
 456 
MEF cell culture, transfection and cellular proliferation measurements 457 
WT and TAZKO MEF cells were cultured at 37°C under a 5% CO2 humidified atmosphere in 458 
Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% [v/v] fetal bovine serum 459 
(FBS) (GIBCO, Invitrogen). Cell growth kinetics was studied under different growth 460 
conditions by plating 1x105 cells in media containing 0.9 g/L galactose. Cell counts were 461 
performed using a haemocytometer at the interval of 24 hours. In some cases, the indicated 462 
concentration of valine was added to the medium. 463 
The transfection ofWT and TAZKO MEF cells (1x107) was performed by electroporation with 464 
20 μg empty pCDNA5.1 plasmid or pCDNA5.1 containing the cDNA of either BCAT1 or 465 
BCAT2 at 1350 V with a single pulse of 30 ms using the Neon Transfection System (Thermo 466 
Fisher Scientific). Immediately after the electroporation, the cells were plated in glucose-467 
containing media for 24 hours. Next, 2.5x105 cells of each experimental condition were re-468 
plated in galactose-containing media for cell counts.  469 
 470 
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Figure legends           620 
Fig. 1. Bat1 and Bat2 are multi-copy suppressors of taz1Δ growth defect. (A) WT and taz1Δ 621 
cells were grown at 30°C in liquid medium and then five-fold serial dilutions were spotted on 622 
synthetic medium containing glucose (SD), glycerol (SG), or acetate (SA). WT and taz1Δ cells 623 
transformed with an empty plasmid (Ø) as well as taz1Δ cells expressing plasmid-born Taz1 624 
were cultured as above and spotted on ethanol-containing synthetic medium lacking leucine 625 
(SE-Leu). (B) taz1Δ cells were transformed with the empty plasmid pFL44L, a plasmid 626 
encoding TAZ1 (pYX142-TAZ1), or with plasmids of the genomic library isolated from positive 627 
candidates of the screen (#13, 15, 16, 29, two colonies each). Cells were analysed by drop 628 
dilution assay on SE medium at 30°C. Plasmid #16 harbors BAT1 and CRG1 whereas #29 629 
harbors COX24 and HMX1. (C) WT and taz1Δ cells genomically overexpressing COX24, 630 
CRG1 or HMX1 were analysed at 30°C by drop dilution assay on SE medium. (D) WT and 631 
taz1Δ cells as well as taz1Δ cells genomically overexpressing either BAT1 or BAT2 were 632 
analysed by drop dilution assay at 30°C on SE medium. (E) WT, gep4Δ, or crd1Δ cells as well 633 
as gep4Δ and crd1Δ cells genomically overexpressing either BAT1 or BAT2 were analyzed by 634 
drop dilution assay at 37°C on YPG medium or at 30°C on YPD medium.  635 
 636 
 Fig. 2. Overexpression of BAT1 or BAT2 does not rescue several defects of taz1Δ cells. (A- 637 
B) Mitochondria isolated from the indicated strains were lysed with 1% digitonin and subjected 638 
to a 6-14% BN-PAGE. Proteins were analysed by immunodetection with an antibody against 639 
either Rip1, a subunit of complex III (A) or Cox2, asubunit of complex IV (B). Supercomplexes 640 
of the respiratory chain complexes are indicated. (C) Membrane potential (ΔΨ) of mitochondria 641 
isolated from the indicated strains was determined by a fluorescence assay. The fluorescence 642 
signal of control organelles was set to 100%. Average values ± S.D. bars of three independent 643 
experiments are shown. (D) Lipids extracted from the mitochondria fraction of the indicated 644 
cells were analyzed by TLC and staining with molybdenum blue. The migration behavior of 645 
standard phospholipids are indicated. (E) The indicated amounts of mitochondria isolated from 646 
the specified strains were analysed by SDS-PAGE and immunodecoration with the indicated 647 
antibodies.  648 
 649 
Fig. 3. Supplementation with some amino acids enhances growth of taz1Δ cells. (A-B) The 650 
indicated cells were analysed by drop dilution assay at 30°C on SE medium supplemented with 651 
the specified concentrations of the amino acids valine (Val) (A) or aspartate (Asp) (B). The 652 
21 
 
lower panel in A depicts a plate that has a gradient of valine concentration from 0.12 mM to 653 
6.4 mM, whereWT or taz1Δ cells were spotted at the indicated OD600.  (C) Lipids extracted 654 
from mitochondria grown in the absence of presence of 5 mM aspartate (D) or 6.4 mM valine 655 
(V) were analyzed by TLC and stained with molybdenum blue . (D-E) The indicated cells were 656 
analysed by drop dilution assay at 30°C on SE medium supplemented with the indicated 657 
concentrations of glutamate (Glu) (D) or histidine (His) (E).  (F) WT and taz1Δ cells as well as 658 
taz1Δ cells genomically overexpressing either AVT1 or AVT4 were analyzed by drop dilution 659 
at 30°C on SE medium. 660 
 661 
Fig. 4. The levels of some metabolites are altered in taz1Δ cells and restored upon 662 
overexpression of BAT1. The indicated metabolites were extracted from the specified cells 663 
grown in ethanol-containing media and were analysed by LC-MS. The relative peak area of 664 
each metabolite was determined and the levels in control WT cells were taken as 100%. Mean 665 
values ± S.D. of six independent experiments are shown. *, p < 0.05; **, p < 0.01; ***, p < 666 
0.001.  667 
 668 
Fig. 5. Overexpression of BCATs or valine supplementation increases cell proliferation of 669 
TAZ-/- MEF cells. (A) WT and TAZKO MEF cells were transfected with an empty plasmid 670 
(MOCK) or with a plasmid overexpressing either BCAT1 or BCAT2. Cells were cultivated in 671 
media containing galactose for the indicated time periods before cell counts were performed (± 672 
SEM, n=3). (B) WT and TAZKO MEF cells were supplemented with the indicated amounts of 673 
valine (Val) and cell count was performed after 72 hours (± SEM, n=3). *, p < 0.05; ***, p < 674 
0.001. 675 
 676 
 677 
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Supplementary Table 1. Strains used in this study. 
Name Genotype Source 
WT (W303) 
leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-
11,15 
N/A 
WT (BY4741) his3-1 leu2-0 met15-0 ura3-0 N/A 
crd1Δ BY4741; crd1Δ::HIS3MX6 current study 
gep4Δ BY4741; gep4Δ::KANMX4 (Sauerwald et al., 2015) 
crd1Δ-BAT1 BY4741; crd1Δ::HIS3MX6 BAT1::natNT2-
GPDpr-BAT1 
current study 
crd1Δ-BAT2 BY4741; crd1Δ::HIS3MX6 BAT2::natNT2-
GPDpr-BAT2 
current study 
gep4Δ-BAT1 BY4741; crd1Δ::KANMX4 BAT1::natNT2-
GPDpr-BAT1 
current study 
gep4Δ-BAT2 BY4741; gep4Δ::KANMX4 BAT2::natNT2-
GPDpr-BAT2 
current study 
WT-LEU2 W303α LEU2::natNT2-GPDpr-LEU2 current study 
taz1Δ W303α; taz1Δ::HIS3MX6 current study 
bat1Δ W303α; bat1Δ::HIS3MX6 current study 
bat2Δ W303α; bat2Δ::HIS3MX6 current study 
taz1Δ-BAT1 W303α; taz1Δ::HIS3MX6 BAT1::natNT2-GPDpr-
BAT1 
current study 
taz1Δ-BAT2 W303α; taz1Δ::HIS3MX6 BAT2::natNT2-GPDpr-
BAT2 
current study 
taz1Δ-LEU2 W303α; taz1Δ::HIS3MX6 LEU2::natNT2-
GPDpr-LEU2 
current study 
taz1Δ-AVT1 W303α; taz1Δ::HIS3MX6 AVT1::natNT2-GPDpr-
AVT1 
current study 
taz1Δ-AVT4 W303α; taz1Δ::HIS3MX6 AVT4::natNT2-GPDpr-
AVT4 
current study 
  
Supplementary Table 2. Plasmids and primers used in this study. 
Plasmids Promoter Markers Reference 
pFL44L - URA3, AmpR (Stettler et al., 1993) 
pYX142-Taz1 TPI LEU2, AmpR current study 
pYM-N15  GPD natNT2, AmpR (Janke et al., 2004) 
 
Primers for deletion by gene-targeting 
DAFwd012 
5’-ATA TTT CAT TTT CAA AAA AAA AAA AAG TAA AGT 
TTT CCC TAT CAA CGT ACG CTG CAG GTC GAC-3’ 
DARev011 
5’-GAC CTC ATA CAT GCT AGT ATT TAC ACG AAT TTA 
ATT GCT TAA ATT ATC GAT GAA TTC GAG CTCG-3’ 
DAFwd032  
5‘-CAC CCT ATA AAC GCA AAA TCA GCT AGA ACC TTA 
GCA TAC TAA AAC CGT ACG CTG CAG GTC GAC-3‘ 
DARev034  
5‘-GTT TTT TTT TTT TGG GGG GGG AGG GGA TGT TTA 
CCT TCA TTA TCA ATC GAT GAA TTC GAG CTCG-3‘ 
DAFwd033  
5‘-TTT AGA AAT TTA AGG GAA AGC ATC TCC ACG AGT 
TTT AAG AAC GAT CGT ACG CTG CAG GTC GAC-3‘ 
DARev035  
5‘-TAT TCT TTT TAA CTT TTA ATT ACT TTA CGT AGC 
AAT AGC GAT ACT ATC GAT GAA TTC GAG CTCG-3‘ 
DAFwd039 
5‘-ACA AGC AGG CCT GGT AGC ATA GTT TGG TCC CTA 
ATA ATT TAG TCA CGT ACG CTG CAG GTC GAC-3‘ 
DARev042 
5‘-CAA AAT GAA AAG TCA GGA CCC TTT TCA AAA AGG 
ATC GCA ATT ATA  ATC GAT GAA TTC GAG CTCG-3‘ 
Primers for introducing open reading frames into pYX plasmids 
DAFwd015 
5’-GGG GAA TTC ATG TCT TTT AGG GAT GTC CTA GAA 
AGA GGA GAT-3’ 
DARev014 
5’-GGG AAG CTT TCA ATC ATC CTT ACC CTT TGG TTT 
ACC CTC TGG A-3’ 
Primers for genomic N-terminal overexpression  
BAT1 N’ tag 
pYM F 
5‘-AAA CGC AAA ATC AGC TAG AAC CTT AGC ATA CTA 
AAA CAT GCG TAC GCT GCA GGT CGA C-3‘ 
BAT1 N’ tag 
pYM R 
5‘-TGA TGG AGA ATT TCC CCA ACT TCA AGG AAT GTC 
TCT GCA ACA TCG ATG AAT TCT CTG TCG-3‘ 
BAT2 N’ tag 
pYM F 
5‘-TTT AAG GGA AAG CAT CTC CAC GAG TTT TAA GAA 
CGA TAT GCG TAC GCT GCA GGT CGA C-3‘ 
BAT2 N’ tag 
pYM R 
5‘-TAG TTA TCT TAA CTT TGG AGG CGT CTA GGG GTG 
CCA AGG TCA TCG ATG AAT TCT CTG TCG-3‘ 
COX24 N’ tag 
pYM F 
5‘-CCA AGA CGA GCA CAC ACG ACA CCA GAA CGA GAT 
AAA CAT GCG TAC GCT GCA GGT CGA C-3‘ 
COX24 N’ tag 
pYM R 
5‘-TAG TAA TGC CCA GCC ACC CAG GTC GCA ATG CCC 
TTC CTA GCA TCG ATG AAT TCT CTG TCG-3‘ 
CRG1 N’ tag 
pYM F 
5‘-CTT CAA AGC CAG TCT TCT GTC AAT GGA AGA ATC 
CAG AAT GCG TAC GCT GCA GGT CGA C-3‘ 
CRG1 N’ tag 
pYM R 
5‘-GAG CAG ATT CAA AAT TTT TGT TTA AAT AAC TAG 
TTT TAG GCA TCG ATG AAT TCT CTG TCG-3‘ 
HMX1 N’ tag 
pYM F 
5‘-GCA TAT ATA CAC ACA CAC ACA TAA AAT AAC CGC 
AAA AAT GCG TAC GCT GC AGG TCG AC-3‘ 
HMX1 N’ tag 
pYM R 
5‘-CGT CAG TGG GTG AGG GTA TGA TTG TAT TGC TAC 
TGT CCT CCA TCG ATG AAT TCT CTG TCG-3‘ 
DAFwd038  
5‘-AAT ATA TAT ATA TAT ATT TCA AGG ATA TAC CAT 
TCT AAT GCG TAC GCT GCA GGT CGA C-3‘ 
DARev040  
5‘-CGT GGT CAC CTG GCA AAA CGA CGA TCT TCT TAG 
GGG CAG ACA TCG ATG AAT TCT CTG TCG-3‘ 
DAFwd044  
5‘-GAC TTA CGT ATT CTG TAT AAC TGA TTC CGA GAC 
GCA AAT GCG TAC GCT GCA GGT CGA C-3‘  
DARev046  
5‘-AGC GCT TAC GGC CAT TGG GAC TCA ATG GTT CTT 
GCT CAG GCA TCG ATG AAT TCT CTG TCG-3‘ 
DAFwd045  
5‘-TGG AAT CAA CAT AAC AAT ATC CTA GAA CAC ATC 
ATC AAT GCG TAC GCT GCA GGT CGA C-3‘ 
DARev047  
5‘-TTC GGA TCC CAA GGT GCT CAC CAT CTC CAT TGT 
TAG TGA CCA TCG ATG AAT TCT CTG TCG-3‘ 
Primers for screening PCR of gene-targeting 
DAFwd013 5’-CAG TAT TTC TAT TAC GTT ACT CCA G-3’ 
DARev012   5’-TTA TAT GGT AGT GTT GCC CAA ACT A-3’ 
DAFwd014   5’-ATG TCT TTT AGG GAT GTC CTA GAA A-3’ 
DARev013   5’-GGG CGG GGA GTA GGC TTT TTT TAG C-3’ 
DAFwd034  5‘-GCG GTT GAT ACT TTG TGC AGA TTT C-3‘ 
DARev036  5‘-ATA CCT TGG CAA CTA AAT TAC AAG C-3‘ 
DAFwd035 5‘-ATG TTG CAG AGA CAT TCC TTG AAG T-3‘ 
DARev037 5‘-AGT GCC AAC ACC TAA ACC CTT GGA T-3‘ 
DAFwd036   5‘-AAT CTG TAG ATC CGA CTC TTT TTC T-3‘ 
DARev038  5‘-GAG TTG CTT CTA AGG TAT GTA TGG G-3‘ 
DAFwd037  5‘-ATG ACC TTG GCA CCC CTA GAC GCC T-3‘ 
DARev039  5‘-GTA ATA AGG ACC CAC AGG GCA GCA A-3‘ 
DAFwd042 5’-CGA CAG AGA ATT CAT CGA TG-3’ 
BAT1 N’tag 
CHK R 
5‘-GTT GGC AAA CAA ATT CTA GC-3‘ 
BAT2 N’tag 
CHK R 
5‘-TAG TGC CGA TTA ATG TAG GC-3‘ 
COX24 N’tag 
CHK R 
5‘-GCT TTC TTC TTT CTG CCT TC-3‘ 
CRG1 N’tag 
CHK R 
5‘-GAA TGC AAA AGT TCC ATC AC-3‘ 
HMX1 N’tag 
CHK R 
5‘-TGT GTA TGT TTT CGT GGA TG-3‘ 
DARev041 5‘-ACT TCT GGA ACG GTG TAT TG-3‘ 
DAFwd040   5’-CGT TTG GCA AAC AAT TAC AGG AAG A-3’ 
DARev043  5’-TGT TAG ACG ATC TGG TAC TAC GAA C-3’ 
DAFwd041 5’-ATG ATT CAA ATG GTG CCC ATT TAT T-3‘ 
DARev044  5’-TAT AAA CAA AGC ACT TAT GGC TAG T-3‘ 
DARev048  5‘-TTGTTGAATTTTGGATGGAC-3‘ 
DARev049  5‘-CAGCGCTACTCAGGTTAGTC-3‘ 
.  
Supplementary Table 3. Antibodies used in this study. 
Antibodies Dilution Source 
polyclonal rabbit anti-Aco1  1 :7000 Lab stocks 
polyclonal rabbit anti-Bmh1  1 :1500 Lab stocks 
polyclonal rabbit anti-Bat1 1:3000 Kindly provided by Roland Lill  
polyclonal rabbit anti-Cor1 1:2000  Lab stocks 
polyclonal rabbit anti-Cox2 1:1000  Lab stocks 
polyclonal rabbit anti-Dld1 1:1000  Lab stocks 
polyclonal rabbit anti-F1β 1:500 Lab stocks 
polyclonal rabbit anti-Fum1 1:10000 Lab stocks 
polyclonal rabbit anti-Rip1 1:5000 Lab stocks 
polyclonal rabbit anti-Tom40  1:4000 Lab stocks 
polyclonal rabbit anti-Tom70 1:2000 Lab stocks 
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Abstract 
Loss of ER-Mitochondria Encounter Structure (ERMES) contact-sites between the yeast endoplasmic 
reticulum (ER) and mitochondria impairs respiration. However, the molecular reason for this is not 
known. By analyzing the transcriptional response of ERMES deletion mutants, we find a specific 
increase in the levels of mRNAs encoding for enzymes involved in the biosynthesis of coenzyme Q6 
(CoQ6), an essential electron transfer molecule in the respiratory chain. We show that the mega 
complex of polypeptides involved in CoQ6 biosynthesis (CoQ synthome) is destabilized in contact-site 
mutants affecting the levels of CoQ6 and its intermediates in mitochondria and the whole cell. We 
suggest that this effect is due to inefficient CoQ6 biosynthesis and escape of CoQ6 and intermediates 
from mitochondria. Fluorescence microscopy shows the enrichment of the CoQ synthome underlying 
ERMES contact sites. The collaboration between the ER and mitochondria in regulating respiration 
highlights an additional level of communication between these two organelles.  
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Introduction 
Over the past two decades, our view on the architecture of the eukaryotic cell has been gradually 
altered. The original view of solitary organelles scattered sparsely in the cytosol has been replaced by 
an understanding that organelles are arranged within a more complex architecture. In fact, organelles 
are tightly packed together, and are anything but solitary. All organelles have the capacity to be 
tethered one to another, by designated structures termed membrane contact sites (Kakimoto et al., 
2018; Shai et al., 2018; Valm et al., 2017). Contact sites are areas where the membranes of two 
organelles come into proximity through the use of tethering molecules. Such areas of close apposition 
allow the transfer of metabolites and other molecules between the two organelles (Eisenberg-Bord et 
al., 2016). One of the most studied contact sites forms between the endoplasmic reticulum (ER) and 
mitochondria. This contact site has n important role in transfer of calcium and phospholipids between 
the two organelles (Herrera-Cruz and Simmen, 2017).  
 
A major complex promoting association of the ER and mitochondria in the budding yeast 
Saccharomyces cerevisiae (hereafter termed 'yeast') is the ER-Mitochondria Encounter Structure 
(ERMES) (Kornmann et al., 2009). ERMES is composed of four subunits: two mitochondrial subunits 
(Mdm10 and Mdm34), an ER subunit (Mmm1) and a soluble subunit (Mdm12). ERMES mutants show 
severe phenotypes including loss of mitochondrial morphology, increased loss of mitochondrial DNA, 
and reduced respiration capacity (Berger et al., 1997; Hobbs et al., 2001; Kornmann et al., 2009; 
Youngman et al., 2004). ERMES was also shown to have a role in mediating mitochondrial dynamics 
(Friedman et al., 2011; Murley et al., 2013), mitophagy (Böckler et al., 2014), life and death decisions 
(Smethurst and Cooper, 2016) and iron metabolism (Xue et al., 2017).  
 
One of the most studied roles of the ERMES complex is the transfer of phospholipids. As mitochondria 
can only partially synthesize the lipids that they require, phospholipids, sterols and 
ceramide/sphingolipids must be imported from the ER. The ER-mitochondria contact sites 
accommodate many lipid transfer enzymes and proteins that are involved in lipid metabolism (Dimmer 
and Rapaport, 2017). Recently it was shown that the Mmm1-Mdm12 complex can mediate 
phospholipid transfer in vitro and that mutations in MMM1 or MDM12 lead to impaired phospholipid 
transfer through the ERMES complex in vivo (Kawano et al., 2018). However, ERMES mutants show 
only a mild decrease in specific phospholipids due to the existence of compensatory mechanisms for 
phospholipid transfer to mitochondria (Elbaz-Alon et al., 2014, 2015; Hönscher et al., 2014). Despite a 
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wealth of information on the ERMES complex, why its loss causes respiratory deficiency has not yet 
been fully elucidated. Hence, we set out to uncover the role of ERMES in regulating respiration.  
 
Here we show that ERMES mutants have increased levels of mRNAs encoding proteins that participate 
in the coenzyme Q6 (CoQ6) biosynthesis pathway. CoQ6 is a polyisoprenylated benzoquinone lipid that 
functions in the electron transport chain of the inner mitochondrial membrane of yeast and also acts as 
a lipophilic antioxidant (Awad et al., 2018; Tran and Clarke, 2007). All the steps required for the 
assembly of the polyisoprenoid diphosphate tail of C Q, its ligation to aromatic ring precursors, and 
modification of the ring precursor, occur within the mitochondria by Coq enzymes associated with the 
matrix side of the mitochondrial inner membrane (Awad et al., 2018; Bentinger et al., 2010). Many of 
the Coq polypeptides (Coq3-Coq9 and Coq11) assemble in a mega-complex termed the CoQ synthome 
(Allan et al., 2015; Belogrudov et al., 2001; He et al., 2014; Marbois et al., 2005, 2009). However, 
synthesis of the polyisoprenoid tail of CoQ6 originates from compounds that derive from the 
mevalonate pathway associated with the ER, suggesting that the ER-mitochondria contact site might 
promote movement of CoQ6, its intermediates or precursors, between these two organelles.  
 
Indeed, we show that the CoQ synthome is destabilized in ERMES mutants resulting in inefficient de 
novo CoQ6 biosynthesis. Such compromised synthesis also results in accumulation of early- and late-
stage CoQ6 intermediates, as well as buildup of CoQ6 at non-mitochondrial cellular membranes. We 
further demonstrate that ERMES mutants harbor decreased steady state levels of CoQ6 and CoQ6-
intermediates within mitochondria. Taken together, the data indicate that the CoQ synthome is possibly 
involved in stabilizing CoQ6 and CoQ6-intermediates and retaining them inside mitochondria. 
Furthermore, ERMES mediated contacts seem to be localized above specialized matrix niches where 
the CoQ synthome is enriched, suggesting a spatially regulated process. Collectively, our study 
provides new insights into the relevance of the ER-mitochondria contact to CoQ6 homeostasis and, 
more broadly, to respiration.  
  
Materials and Methods 
Yeast strains and plasmids 
Saccharomyces cerevisiae strains and plasmids used in this study are listed in Table S1 and Table S2, respectively. Yeast 
strains were based on the laboratory strain S288C (BY4741) (Baker Brachmann et al., 1998) or W303 (Thomas and 
Rothstein, 1989). Transformations of PCR fragments into yeast cells were performed using the Li -acetate method (Gietz 
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and Woods, 2006; Janke et al., 2004; Longtine et al., 1998). Primers were designed using Primers-4-Yeast (Yofe and 
Schuldiner, 2014). 
 
RNA-Sequencing 
S288C (BY4741) cells were grown overnight in a synthetic medium SD (2% [wt/vol] glucose, 0.67% [wt/vol] yeast 
nitrogen base with ammonium sulfate and amino acid supplements) at 30°C. W303 cells were grown overnight in a 
synthetic medium SGly (2% [wt/vol] glycerol, 0.67% [wt/vol] yeast nitrogen base with ammonium sulfate and amino acid 
supplements) at 30°C. In the morning, cells were back-diluted to OD600~0.01 and grown until reaching OD600~ 0.2. Cells 
were centrifuged (3000 g, 3 min), and the pellet was frozen in liquid nitrogen and stored at −80°C until further analysis. 
 
For all samples, RNA was purified as described in (Voichek et al., 2016). Briefly, RNA was extracted according to a 
protocol of Nucleospin® 96 RNA kit (Machery-Nagel) with two modifications: lyis was performed by adding 450 μl of 
lysis buffer containing 1 M sorbitol, 100 mM EDTA and 0.45 μl lyticase (10 I U/μl) to cells in a 96 deep-well plate. The 
plate was then incubated for 30 min at 30°C, centrifuged (3000 g, 10 min) and the supernatant was removed. In addition, 
dithiothreitol was used as a replacement for β-mercaptoethanol.  
 
For S288C cells, RNA was fragmented, poly(A) selected, followed by cDNA preparation, barcoding, and sequencing using 
Illumina HiSeq 2500, as described (Voichek et al., 2016). For W303 cells, RNA libraries were created by reverse 
transcription with a barcoded poly(T). DNA-RNA hybrids were pooled, followed by use of a hyperactive variant of the Tn5 
transposase (gift from Ido Amit, Weizmann Institute of Science, Israel) for fragmentation. SDS (0.2%) was used to strip 
Tn5 off the DNA. Following SDS treatment, samples were purified using SolidPhase Reversible Immobilisation (SPRI) 
(Beckman Coulter) beads. cDNA was then amplified using PCR and sequenced using the Illumina NextSeq 500. Single end 
reads were then mapped to S. cerevisiae genome (R64 in SGD) (Cherry et al., 2012) using bowtie (parameters: --best –a –m 
2 –strata -5 10) (Liu et al., 2005). Following alignment, reads mapped to rRNA were excluded. For S288C samples, reads 
were down sampled to 400,000 reads and normalized for PCR bias using the unique molecular identifier (UMI) (Kivioja et 
al., 2012). For all samples, expression of each gene was the summary of reads aligned between 400bp upstream and 200bp 
downstream of the predicted open reading frame. The gene expression summary was normalized to be 1,000,000 and a gene 
with an expression below 10 was excluded from further analysis (Vo chek et al., 2016).  Each sample was run twice and 
values shown are typically the average of the two. However, if only one sample had a value, that value was provided. 
 
Mitochondrial purification from yeast 
Yeast wild-type and ERMES mutant cultures were grown in YPGly (1% [wt/vol] Bacto yeast extract, 2% [wt/vol] Bacto 
peptone, 3% glycerol) at 30°C. Cells were harvested at OD600 of < 4.0, and mitochondria were purified with discontinuous 
Nycodenz as described (Glick and Pon, 1995). Roche Complete EDTA-free protease inhibitor mixture, phosphatase 
inhibitor cocktail set II (EMD Millipore) and phosphatase inhibitor cocktail set 3 (Sigma-Aldrich) were added to the 
solutions. Gradient-purified mitochondria were frozen in liquid nitrogen and stored at −80°C until further analysis. 
Mitochondria from yeast Δcoq mutants were purified in the same manner from cultures grown in YPGal medium (1% 
[wt/vol] Bacto yeast extract, 2% [wt/vol] Bacto peptone, 2% [wt/vol] galactose, 0.1% [wt/vol] dextrose). 
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SDS-PAGE analysis of steady state levels of Coq polypeptides  
Purified mitochondria were resuspended in SDS sample buffer consisting of 50 mM Tris, pH 6.8, 10% glycerol, 2% SDS, 
0.1% bromophenol blue, and 1.33% β-mercaptoethanol and proteins were separated by SDS-PAGE on 12% Tris-glycine 
polyacrylamide gels. An aliquot of 25 μg of purified mitochondria, as measured by the bicinchoninic acid (BCA) assay 
standardized using bovine serum albumin (BSA), was loaded in each lane.  
 
Two-dimensional BN- and SDS-PAGE analysis of CoQ synthome 
Analysis of protein complexes by blue native (BN) gel electrophoresis was performed as previously described (Schagger et 
al., 1994; Wittig et al., 2006). Briefly, an aliquot of 200 μg protein of purified mitochondria was pelleted by centrifugation 
(14000 g, 10 min) and solubilized at a concentration of 4 mg protein /ml on ice for 1 hr with BN solubilization buffer 
containing 11 mM HEPES, pH 7.4, 0.33 M sorbitol, 1X NativePAGE sample buff r (Thermo Fisher Scientific), 16 mg/ml 
digitonin (Biosynth), Roche Complete EDTA-free protease inhibitor mixture, phosphatase inhibitor cocktail set II, and
phosphatase inhibitor cocktail set 3. The soluble fraction was obtained by centrifugation (100,000 g, 10 min) and the protein 
concentration in the supernatant was determined by BCA assay. NativePAGE 5% G-20 sample additive (Thermo Fisher 
Scientific) was added to the supernatant to a final concentration of 0.25%. The first-dimension BN gel electrophoresis was 
performed using NativePAGE 4-16% Bis-Tris gel 1.0 mm x 10 wells (Thermo Fisher Scientific). First-dimension gel slices 
were soaked in hot SDS sample buffer for 15 min before loading them onto second dimension 12% Tris-glycine 
polyacrylamide gels. The high molecular weight standards for first-dimension BN gel electrophoresis were obtained from 
GE Healthcare (Sigma-Aldrich) [Cat. GE17-0445-01], and the molecular weight standards for second dimension SDS-
PAGE were obtained from Bio-Rad [Cat. 1610394]. 
 
Immunoblot analyses  
Proteins were transferred onto 0.45 μm nitrocellulose membrane (Bio-Rad). Membranes were blocked in 0.5% BSA, 0.1% 
Tween 20, 0.02% SDS in phosphate-buffered saline. Membranes were probed with primary antibodies (Table S3) in the 
same blocking buffer at the dilutions listed in Table S3. IRDye 680LT goat anti-rabbit IgG secondary antibody, or IRDye 
800CW goat anti-mouse IgG secondary antibody (LiCOR) were used at 1:10,000 dilutions. Blot images were recorded 
using LiCOR Odyssey Infrared Scanner (LiCOR).  
 
Stable isotope labeling 
Cells were grown overnight in 100 ml of YPGly in a shaking incubator (30°C, 250 rpm) and diluted the next morning to an 
OD600 ~0.1 with fresh YPGly. The cultures were incubated as before until they reach an OD600 of 0.6 and then 8 μg/ml of the 
stable isotopes 13C6-pABA, 13C6-4HB, or ethanol (as vehicle control) were added and the cultures were grown for additional 
5 hr. At each time point, triplicates of 10 ml culture were harvested by centrifugation (3000 g, 5 min). Cell pellets were stored 
at −20°C. 
 
Lipid extractions and analysis of CoQ6 and CoQ6 intermediates 
For lipid extraction, approximately 100 μg of purified mitochondria from each strain were prepared in triplicates, and same 
amount of internal standard CoQ4 were added to all samples and standards, followed by addition of 2 ml methanol. Lipids 
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were extracted twice, each time with 2 ml petroleum ether. Extracted lipids were dri d down with N2 and stored at −20°C. 
Lipid extraction from isotopically-labeled whole cell was performed in the same way from frozen cell pellets in triplicates. 
 
For lipid analysis, dried lipids were reconstituted in 200 μl of 0.5 mg/ml benzoquinone in order to oxidize hydroquinones to 
quinones. An aliquot of 20 μl of each sample was injected into a 4000 QTRAP linear MS/MS spectrometer (Applied 
Biosystems). Applied Biosystems software, Analyst version 1.4.2, was used for data acquisition and processing. The 
chromatographic separation was carried out using a Luna 5 μm phenyl-hexyl column (100 x 4.6 mm, 5 μm; Phenomenex) and 
a mobile phase consisted of 95:5 methanol/isopropanol solution with 2.5 mM ammonium formate as solution A and 100% 
isopropanol solution with 2.5 mM ammonium formate as solution B. The percentage of solution B was increased linearly 
from 0 to 10% over 7 min, whereby the flow rate was increased from 650 to 800 μl/min. Each sample was analyzed using 
multiple reaction monitoring mode (MRM). The precursor-to-product ion transitions monitored for each sample are listed in 
Table S4. The area value of each peak, normalized with the correspondent standard curve and internal standard, was referred 
to the total mitochondrial protein present in the sample or total OD of cells in each cell pellet. Statistical analysis was 
performed with GraphPad Prism with one-way ANOVA for mitochondrial lipid analyses, and with two-way ANOVA for 
whole cell lipid analyses. 
 
Microscopy 
Yeast were cultured overnight at 30°C in either SGly for W303 cells or SD for S288C. In the morning, cells were back-
diluted to OD600~0.2 and grown until reaching mid-logarithmic phase. Cells were then moved t  glass-bottom, 384-well 
microscope plates (Matrical Bioscience) coated with Concanavalin A. After 20 min incubation at room temperature, the 
wells were washed with medium. Cells were then imaged at room temperature using a 60X oil lens (NA 1.4) in the 
VisiScope Confocal Cell Explorer system, which is composed of a Zeiss Yokogawa spinning disk scanning unit (CSU-W1) 
coupled with an inverted IX83 microscope (Olympus). Single–focal-plane images were taken using a PCO-Edge sCMOS 
camera, controlled by VisiView software (GFP-488 nm, RFP-561 nm, or BFP-405 nm). Images were reviewed using 
ImageJ.  
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Results 
Cells lacking ERMES complex subunits up-regulate coenzyme Q biosynthesis transcripts 
To investigate how the ERMES complex contributes to the respiratory capacity of the cell, we set out 
to measure the cellular transcriptional response upon deletion of ERMES subunits. We performed RNA 
sequencing on ERMES mutants from two different genetic backgrounds: W303 cells that preserve their 
mitochondrial DNA while being deleted for each of the four ERMES subunits Mmm1, Mdm10, 
Mdm12 or Mdm34; or S288C (BY4741) cells (who lose their mitochondrial DNA very rapidly) de eted 
for Mmm1, Mdm10 or Mdm12 (The complete list of mRNA levels in ERMES mutants is in Table S5).  
When surveying genes required for respiration, we noticed that the mRNA levels of most COQ genes 
involved in the biosynthesis of CoQ6 were higher relative to those in the respective wild-type control in 
both genetic backgrounds (Figure 1A for W303 and Figure S1A for S288C), while the mRNA levels of 
genes encoding subunits of respiration complexes did not show a consistent trend of either up- or 
down-regulation (Figure S1B).  
We therefore tested whether the higher mRNA levels of the COQ genes resulted in higher protein 
levels of those polypeptides in mitochondria purified from W303 cells (Figure 1B). We examined the 
steady state levels of Coq proteins that have previously been identified as members of the CoQ 
synthome, as well as Coq10, which is not part of the CoQ synthome but is thought to chaperone CoQ6 
from the synthome to sites of function (Allan et al., 2013; Barros et al., 2005). Surprisingly, we 
observed that the steady state levels of all Coq proteins in the mutants were either similar or even 
slightly reduced relative to the control (Figure 1B).  
 
The CoQ synthome is destabilized in the absence of ERMES subunits 
As the overall mRNA levels of the COQ transcripts were higher in ERMES deletions, but there was no 
major difference in protein levels, it seems that Coq proteins might be less stable in cells lacking the 
ERMES complex and that up-regulation of transcription is a compensatory mechanism. Since most of 
the Coq polypeptides assemble in the CoQ synthome (Belogrudov et al., 2001; He et al., 2014; Marbois 
et al., 2005, 2009) and proteins may become unstable when not assembled properly into their natural 
complexes, we examined the CoQ synthome by two-dimensional BN-PAGE (Figure 2). Previously the 
CoQ synthome was studied when galactose was used as a carbon source (He et al., 2014; Nguyen et al., 
2014). However, to prevent loss of mitochondrial DNA (that occurs frequently in these strains) we 
followed Coq4, Coq5 and Coq9 in mitochondrial lysates from yeast grown on glycerol as the sole 
carbon source. As expected, in wild-type cells Coq4, Coq5, and Coq9 were detected in one relatively 
discrete complex greater than 669 kDa. However, in the ERMES mutant strains, a large fraction of the 
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proteins was found in more rapidly migrating sub-complexes equal to or less than ~440 kDa (Figure 
2A, B). Based on this analysis, it appears that the CoQ synthome is destabilized in the absence of the 
ERMES complex.  
 
ERMES deletion strains show elevated de novo synthesis of CoQ6 and accumulate CoQ6 and CoQ6-
intermediates in whole cells 
To quantify how the biosynthesis of CoQ6 is affected by destabilization of the synthome in ERMES 
mutants we measured its rate of synthesis. Yeast cells may utilize either para-aminobenzoic acid 
(pABA) or 4-hydroxybenzoic acid (4HB) as ring precursors of C Q6 (Marbois et al., 2010; Pierrel et 
al., 2010). Early-stage intermediates, hexaprenyl-aminobenzoic acid (HAB) and hexaprenyl-
hydroxybenzoic acid (HHB) are derived from prenylation of pABA or 4HB, respectively. Subsequent 
modifications of the aromatic ring produce late-stage intermediates demethyl-demethoxy-Q6H2 
(DDMQ6), and demethoxy-Q6H2 (DMQ6), which eventually lead to production of Q6H2 (for a 
schematic of the pathway see Figure 3A). The amino substituent on the pABA ring is removed by a 
combination of Arh1, Yah1, Coq6 and Coq9 (He et al., 2015; Ozeir et al., 2015) and 4-imino-demethyl-
demethoxy-Q6H2 (IDDMQ6) and 4-imino-demethoxy-Q6H2 (IDMQ6) likely represent dead-end 
products.  
To determine whether CoQ6 production was altered in the ERMES deletion strains, we analyzed de 
novo biosynthesis of 13C6-CoQ6 with 13C ring-labeled precursors, namely 13C6-pABA and 13C6-4HB. 
Surprisingly, we saw that Δmdm10, Δmdm12, and Δmdm34 cells showed enhanced de novo synthesis of 
13C6-CoQ6 (Figure 3B). These mutants also accumulated CoQ6-intermediates emanating from 13C6-
pABA and 13C6-4HB (Figure 3C-G), whereas Δmmm1 cells only contained significantly higher amount 
of 13C6-labeled HAB and HHB, but not of other intermediates (Figure 3C-G). We also measured the 
levels of non-labeled CoQ6 (which correspond to the steady state levels) in the same samples, and 
observed an accumulation of unlabeled CoQ6 and CoQ6-intermediates in most of the ERMES deletion 
mutants, regardless of the presence or absence of 13C-labeled precursor (Figure S2).  
The increased rate of production and accumulation of CoQ6-intermediates in the ERMES deletion 
mutants suggests a compensatory over-activation of the pathway that occurs when the catalytic 
efficiency of CoQ6 biosynthesis is reduced following CoQ synthome destabilization. 
 
ERMES deletion strains show decreased steady state levels of CoQ6 and CoQ6-intermediates in 
isolated mitochondria 
Although the biosynthesis of yeast CoQ6 occurs exclusively within mitochondria, CoQ6 is present in all 
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cellular membranes. Thus, to focus on the status of CoQ6 in mitochondria, we determined the steady 
state content of CoQ6 in mitochondria isolated from the ERMES deletion mutants as compared to 
control strains. Despite the fact that the overall cellular levels of CoQ6 in these mutants were increased, 
the steady state level of CoQ6 was significantly reduced in mitochondria isolated from three of the four 
ERMES deletion strains namely, Δmmm1, Δmdm10 and Δmdm12 (Figure 4A). Only strains lacking 
Mdm34p appeared to have nearly normal levels of CoQ6. Isolated mitochondria from all of the ERMES 
deletion strains contained also lower levels of the late-stage intermediates DMQ6 (Figure 4F) and 
IDMQ6 (Figure 4E). While the levels of the late-stage intermediate DDMQ6 was reduced in all strains, 
it was not statistically significant for all (Figure 4D). Our finding of decreased steady state level of 
CoQ6 and CoQ6-intermediates in isolated mitochondria suggests that the accumulation of CoQ6 and its 
intermediates as detected in whole cell lipid extracts (Figures 3 and S2) must reside in non 
mitochondrial membranes.   
In the complete absence of the CoQ synthome, strains fail to make CoQ6 and can only carry out the 
first two steps of the biosynthetic pathway, producing HAB or HHB from the prenylation reaction of 
the precursors pABA or 4HB, respectively (He et al., 2014). Indeed, deletion of COQ7 resulted in a 
dramatic accumulation of HAB and HHB (Figure 4B, C), as observed previously (Tran and Clarke, 
2007). Interestingly, in the strains deleted for ERMES subunits, this accumulation of early CoQ6-
intemediates did not occur, with the exception of HHB slightly accumulating in the Δmdm34 strain 
(Figure 4B, C) consistent with a divergent function for Mdm34 (Youngman et al., 2004). The 
difference in the accumulation phenotypes between the ERMES-deletion strains and Δcoq7 indicates 
an additional role for ERMES beside stabilization of the CoQ synthome.  
 
Coq proteins co-localize with ERMES subunits 
Strains lacking ERMES subunits show increased levels of cellular CoQ6 and its intermediates, but 
decreased levels of mitochondrial CoQ6 together with a destabilized CoQ synthome. Therefore, we 
wondered whether the ERMES complex may play a role in organizing the CoQ synthome so that 
metabolites might be efficiently transferred between mitochondria and the ER. In support of such an 
assumption, we noticed that some Coq proteins are not distributed evenly throughout the mitochondrial 
matrix but rather have a more punctate localization, suggesting that there might be distinct areas that 
are dedicated to the synthesis of CoQ6 inside the mitochondrial matrix. Tagging Coq6 and Coq9 with 
GFP, in a strain expressing the ERMES marker Mdm34 tagged with Cherry, in both W303 (Figure 5A) 
and S288C (Figure S1C), revealed that next to each ERMES complex there was a Coq puncta. This 
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suggests that the localization of the CoQ synthome is coordinated with the position of the ER-
mitochondria contact site.  
 
Discussion 
Contact sites play an essential role in shaping the cellular architecture as well as participating in 
transfer of small molecules between organelles thus enabling tight regulation of biochemical pathways. 
In this study, we show that the ERMES complex, which acts as an ER-mitochondria contact site tether, 
also has a fundamental role in regulating CoQ6 biosynthesis and distribution. 
 
The role of ER-mitochondria contacts in CoQ6 synthesis seems to reside on two levels. First, absence 
of the ERMES complex leads to destabilization of the CoQ synthome. This may occur due to even 
small alterations in phospholipid metabolism occurring in these mutants (Kawano et al., 2008; Elbaz-
Alon et al., 2014, 2015; Hönscher et al., 2014) (Figure 5) or may be through another direct, or indirect 
mechanism. Second, there is a spatial coordination of the ERMES complex with the CoQ synthome. 
Currently, there is no evidence showing direct interaction of ERMES subunits with known members of 
the CoQ synthome. Given that ERMES subunits Mdm10 and Mdm34 localize at the mitochondrial 
outer membrane, and members of CoQ synthome are peripheral mitochondrial inner membrane 
proteins, the co-localization result raises an intriguing question, how is the CoQ synthome anchored to 
this location? It was previously shown that Coq4 organizes the CoQ synthome but it probably can not 
traverse the intra-membrane space (Marbois et al., 2009). Although Coq2 is a transmembrane protein 
of the inner mitochondrial membrane, so far there is no evidence that it is associated with the CoQ 
synthome (Awad et al., 2018). Interestingly, in the yeast genome COQ10 and MDM12 genes are 
adjacent and might share a promoter (Cherry et al., 2012). SPELL analysis (Hibbs et al., 2007) 
demonstrates that these two genes are co-regulated. COQ10 encodes a membrane spanning putative 
StART domain protein with a lipid binding pocket for CoQ6, and late-stage CoQ6-intermediates. 
Although Coq10 protein has not been shown to be part of the CoQ synthome, it is necessary for 
efficient de novo CoQ6 biosynthesis and respiration. As many StART domain proteins are involved in 
lipid transport, signal transduction and transcriptional regulation, the regulation of the mRNA 
expression of the COQ10 and MDM12 genes might help coordinate the levels of Coq10 polypeptide 
and the ERMES complex to allow a better positioning of the CoQ synthome next to the ER-
mitochondria contact site.  
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How do CoQ6 and CoQ6-intermediates escape from mitochondria and accumulate in non-mitochondrial 
membranes in the ERMES deletion mutants? Given that many Coq proteins of the CoQ synthome can 
bind CoQ6 or CoQ6-intermediates, one of the possibilities is that the destabilized synthome causes 
reduced ability to retain these molecules in mitochondria (Figure 6). Catechol quinones, unsubstituted, 
or partially substituted quinone intermediates, such as DDMQ6 are notorious for their ability to act both 
as oxidants and electrophiles, rendering oxidative damages to cells (Cavalieri et al., 2002; Waite, 
1990). As oxidants, one electron reduction of these quinone compounds generates semiquinone-like 
reactive oxygen species (ROS) via redox cycling. As electrophiles, these quinone compounds form 
covalent adducts with proteins and other macromolecules, and cause peroxidation of lipid membranes 
(Cavalieri et al., 2002). It is likely that the CoQ synthome is involved in sequestering these reactive 
CoQ6-intermediates. An alternative option is that in ERMES mutants, there is reduced degradation of 
CoQ6 outside mitochondria. Although CoQ6 degradation has not been studied extensively, it is believed 
that degradation of the polyisoprene tail of CoQ6 may be carried out in peroxisomes via both α- and β-
oxidation (Wanders, 2014). We have previously shown that Peroxisome-mitochondria (PERMIT) 
contact sites reside in proximity to ER-mitochondria contact sites (Cohen et al., 2014) and hence loss of 
ERMES may also affect the capacity to degrade escaped CoQ6.  
We believe that the role of the ER-mitochondria contact site in CoQ6 regulation is conserved from yeast 
to mammals. Conditional knock-out mice of mammalian mitofusin 2 (MFN2) show impaired 
respiration resulting from a decrease in their mitochondrial CoQ9 and CoQ10 levels (the mammalian 
forms of CoQ6) (Mourier et al., 2015). It is hypothesized that this is not directly related to the role of 
MFN2 in mitochondrial fusion, since loss of the homologous MFN1 protein, which shares MFN2's 
fusion role, does not result in alterations in CoQ biosynthesis. MFN2 is reported to play an additional 
role as a tether in ER-mitochondria contact sites (de Brito and Scorrano, 2008) suggesting that the loss 
of the ER-Mitochondria tethering is what leads to the altered levels of CoQ biosynthesis similar to loss 
of ERMES components in yeast.  
Why would interplay between CoQ6 biosynthesis and the ER-mitochondria contact site evolve? Hmg1 
and Hmg2 are two ER transmembrane proteins that catalyze the rate-limiting step of the mevalonate 
pathway, required for generating the farnesyl pyrophosphate (FPP) utilized as a precursor for CoQ, on 
the ER membrane (Buhaescu and Izzedine, 2007). In mammalian cells, it was shown that indeed 
inhibiting the homologous enzymes results in decreased CoQ levels (Maltese and Aprille, 1985). Since 
the final synthesis steps of CoQ occur in mitochondria, it is clear that a tight communication between 
the two organelles must be involved. Moreover, FPP serves as a major metabolic junction in the cell as 
it is a limiting precursor for metabolites that have a role in key cellular processes including the 
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production of dolichols (required for glycosylation and protein secretion), sterols and farnesylated 
proteins (required for membrane growth) as well as heme-A, and CoQ (required for respiration) 
(Goldstein and Brown, 1990). Interestingly, the production of these compounds occurs in different 
compartments of the cell, including the cytosol, the ER, and mitochondria. This means that in addition 
to the tight regulation needed to ensure no accumulation of toxic intermediates of the pathway, FPP 
must be diverted and allocated to specific organelles to control distribution of this precursor and the 
relative contribution to protein secretion, respiration or membrane growth. How this occurs is still a 
mystery. Positioning the pathway in areas of organelle-contact suggests a means for spatial regulation 
of this process.  
Recently we have shown that the unfolded protein response (UPR), which coordinates cellular needs 
and protein folding capacity in the ER, is dependent on the mitochondrial biosynthesis (Cohen et al., 
2017). We showed that when mitochondrial function is impaired, and heme is not synthesized properly, 
the UPR will not activate to its fullest capacity due to limited sterol production. Here, we show that 
CoQ6 biosynthesis is also dependent on the cross-talk between the ER and mitochondria. When the 
physical contact between the ER and mitochondria is impaired, this will affect the formation of C Q6 
(and probably heme) from mevalonate precursors, increasing its availability for sterol production. 
Therefore, FPP and Heme may serve as information-rich molecules, each made in one compartment but 
having a role in the other, allowing coordination of the functional capacity of these two organelles. 
More broadly these two coordination loops suggest that at any given moment multiple checkpoints are 
in place to ensure that respiration and secretion are kept in a regulated balance.  
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Figure legends 
Figure 1: Cells lacking ERMES show up-regulation of COQ mRNAs 
(A) Change in mRNA levels of the indicated COQ genes were measured using RNA sequencing in the different W303 
strains deleted for ERMES subunits (Δmmm1, Δmdm10, Δmdm12, and Δmdm34) relative to a control. The majority of COQ 
biosynthetic genes show an up-regulation of their mRNA levels compared to the WT control. Values are Log2 of ERMES 
deletion mutant − Log2 of control and are averages of two biological repeats.  
(B) Immunoblotting for levels of Coq polypeptides from gradient purified mitochondria of W303 mutants of the ERMES 
complex (Δmmm1, Δmdm10, Δmdm12, and Δmdm34), Δcoq (Δcoq3- Δcoq10) and a control, demonstrates that steady state 
levels of the different Coq polypeptides were not dramatically altered in the ERMES deletion strains. Immunoblotting was 
performed with antisera against designated yeast Coq polypeptides (Coq3-Coq10), Mdh1 is a mitochondrial marker, and 
Sec62 is an ER marker. Arrows denote the corresponding protein in their respective blots. Images are representative gels 
from at least two biological repeats.  
 
Figure 2: The CoQ synthome is destabilized in the absence of ERMES subunits 
(A) Two-dimensional blue native/ SDS-PAGE gel electrophoresis analysis of ERMES mutants in W303 background 
(Δmmm1, Δmdm10, Δmdm12, and Δmdm34) compared to a Δcoq4 and a wild-type (WT) control strain. Gels were immuno-
blotted against Coq4. While in control conditions the Coq synthome appears as one discrete band at >669 kDa (the position 
of the band is marked by a yellow arrow), in the ΔERMES strains, the signal appears dispersed over a range of smaller 
molecular weights, indicated by brackets. The red asterisk (*) indicates a discrete non-specific signal observed with the 
antisera to Coq4. 
(B) Two-dimensional Blue Native/ SDS-PAGE gel electrophoresis was performed as described in (A). Δcoq5 was used as 
negative control (In this strain Coq9 is destabilized and undetectable). Gels were immuno-blotted against Coq5 and Coq9. 
The strong Coq5 and Coq9 bands in the higher molecular weight (>669 kDa) in the control conditions (indicated by yellow 
arrows) weaken in the ΔERMES strains and an additional diffuse signal appears in the lower molecular weights (marked by 
brackets). 
 
Figure 3: Biosynthesis of CoQ6 and CoQ6-intermediates is increased in cells lacking the ERMES complex 
(A) Schematic representation of selected steps of the CoQ6 biosynthesis pathway. CoQ6-intermediates that were analyzed 
using mass-spectrometry (MS) are indicated in green text. (B-G) MS-MS analysis for CoQ6 and CoQ6-intermediates in 
whole cell lipid extracts from W303 control, Δmmm1, Δmdm10, Δmdm12, and Δmdm34 strains. 13C6-CoQ6 and 13C6-CoQ6-
intermediates derived from 13C6-pABA are depicted in red, while the 13C6-CoQ6 and 13C6-CoQ6-intermediates derived from 
13C6-4HB are depicted in blue. 13C6-CoQ6 biosynthesis (B) is increased in Δmdm10, Δmdm12, and Δmdm34 strains labeled 
with 13C6-pABA or 13C6-4HB. The biosynthesis of 13C6-HHB (C) and 13C6-HAB (D) is significantly higher in all the 
ERMES deletion strains. The de novo levels of demethyl-demethoxy-Q6 (13C6-DDMQ6) (E), 4-imino-DMQ6 (13C6-IDMQ6) 
(F) and demethoxy-Q6 (13C6-DMQ6) (G) are significantly increased in Δmdm10, Δmdm12, and Δmdm34 strains, with the 
exception of 13C6-DMQ6 in Δmdm34 that did not change after the labeling with 13C6-4HB. Values are means of three 
repeats. The error bar indicates mean ±SD. Statistically significant differences betwen control and each of the ERMES 
mutants are represented by *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0005. 
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Figure 4: Mitochondria from ERMES mutants show less CoQ6 and CoQ6-intermediates 
(A-F) Targeted MS-MS analyses for CoQ6 and CoQ6-intermediates from purified mitochondria from W303 wild-type (WT) 
control, Δmmm1, Δmdm10, Δmdm12, and Δmdm34 strains. Δcoq7 was included as a negative control. Levels of (A) CoQ6 
were significantly reduced in all ERMES deletion strains except for Δmdm34. Levels of (B) HHB and (C) HAB were 
significantly higher in the Δcoq7 strain, however ERMES deletion strains did not show an accumulation of either HHB or 
HAB (with the exception of Δmdm34 accumulating HHB). Levels of (D) DDMQ6 were not significantly changed. Levels of 
(E) IDMQ6 and (F) DMQ6 were significantly reduced in all ERMES deletion strains. Values are means of three biological 
repeats. The error bar indicates mean +SD. Statistically significant differences betwen control and each of the ERMES 
mutants are represented by *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0005. n.d.= not detected.  
 
Figure 5: Members of the CoQ synthome reside in a matrix niche that is underlying the ERMES complex 
(A) Yeast cells expressing the indicated GFP-tagged Coq protein, the ERMES protein Mdm34 tagged with Cherry and a 
Blue Fluorescent Protein (BFP) fused to a mitochondrial targeting sequence (MTS) were imaged using fluorescence 
microscopy. Arrows indicate Coq foci that underlie the ERMES component on parts of the mitochondrion. Bar = 5µM. 
(B) Schematic representation of co-localization of ERMES complex and CoQ synthome. Mdm10 and Mdm34 outer 
mitochondrial membrane proteins are positioned in close proximity with Coq proteins of the CoQ synthome. Coq6 and 
Coq9 that were visualized in (A) are highlighted in orange.  
 
Figure 6. Proposed model of how the absence of ERMES affects CoQ synthome and CoQ6 biosynthesis 
(A) Under normal conditions, the CoQ synthome is well assembled and CoQ6 biosynthesis (represented by red arrow) occurs 
efficiently in mitochondria. This catalytic efficiency ensures that early- nd late-stage CoQ6-intermediates do not accumulate.  
(B) When the ERMES complex is absent, the stability of the CoQ synthome is compromised. A partially destabilized CoQ 
synthome underlies inefficient CoQ biosynthesis, leading to the accumulation of early- and late-stage CoQ6-intermediates that 
fail to be retained within mitochondria. The altered phospholipid metabolism in the ERMES mutants may also indirectly 
contribute to the destabilized CoQ synthome and inefficient catalysis. 
 
Figure S1: Verification of results on an additional yeast strain genetic background 
(A) mRNA levels of the indicated COQ genes as were measured using RNA sequencing in control S288C strains as well as 
in strains deleted for ERMES subunits (Δmmm1, Δmdm10 and Δmdm12). Similar to the W303 background, mRNAs of 
COQ genes show an overall up-regulation of their mRNA levels compared to the wild-type control. Values are Log2 of the 
designated ERMES deletion mutant – Log2 of control and are averages of two repeats.  
(B) mRNA levels of the indicated respiratory genes, as were measured using RNA sequencing in the W303 control and 
ERMES deletion strains. As opposed to the COQ mRNAs, the mRNAs corresponding to genes encoding respiratory 
complexes were not dramatically or consistently altered when compared to the control. Values are Log2 of deletion mutant 
– Log2 of control and are averages of two repeats.  
(C) S288C Yeast cells expressing the indicated GFP-tagged Coq protein, the ERMES protein Mdm34 tagged with Cherry 
and a BFP fused to an MTS were imaged using fluorescence microscopy. Arrows indicate Coq foci that underlie the 
ERMES component on parts of the mitochondrion. Bar = 5µM. 
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Figure S2. Most of the ERMES mutant strains accumulate unlabeled CoQ6 and CoQ6-intermediates. 
(A-F) LC-MS/MS analysis for CoQ6 and CoQ6-intermediates from whole cells of W303 control, Δmmm1, Δmdm10, 
Δmdm12, and Δmdm34 strains. Cells were harvested after 5 hours labeling using 13C6-pABA, 13C6-4HB or ethanol. 13C6-
CoQ6 and 12C-CoQ6 are depicted in the stacked bar graph in panel (A), and both accumulate in most of the ERMES deletion 
mutant strains. For simplicity, only unlabeled CoQ6-intermediates (hence steady state levels of these metabolites) are 
depicted in panels B-F. Similar results were observed for HHB (B) and HAB (C), but the increase is more drastic in the 
absence of 13C6-labeled precursors (see EtOH control). Levels of DDMQ6 (D), IDMQ6 (E) and DMQ6 (F) are significantly 
increased in Δmdm10, Δmdm12, and Δmdm34 strains in all the conditions. Values are means of three repeats. The error bar 
indicates mean +SD. Statistically significant differences between control and each of the ERMES mutants are represented 
by *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0005. 
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